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1  Executive summary 
This rapid review has been commissioned by the Agency for Clinical Innovation (ACI) and the Sax Institute to 
inform decisions on the potential implementation of risk stratification approaches in NSW.  
 
The focus of this review (which will complement others) is the implementation of risk stratification tools. In 
this report, the term risk stratification tool is used to refer to all models, tools and systems that use 
algorithms to predict future risk of mortality, morbidity or health service usage (including hospitalisation, 
rehospitalisation and pre-hospital service usage) for a particular defined population. 
 
Papers that studied or described the adaption of a standard risk stratification tool for a new context or the 
implementation of a tool were included in the review. Studies that examined the development or validation 
of tools, or the testing of their predictive accuracy were excluded. 
 
We undertook a two-pronged approach to search for literature. First, a systematic search was conducted in 
Medline, Embase, Scopus, the Cochrane Library and CINAHL databases. Second, focused searches were 
conducted in peer-reviewed and grey literature for specific risk stratification tools known to the review team 
and provided by ACI.  
 
A total of 30 papers and four research protocols were included for review including eight outcome-based 
evaluations using some form of comparison group; four qualitative evaluations; two comparative case 
studies; six descriptive case studies; five reviews of tools and five implementation guides. 
 
Question 1: What system-wide risk prediction strategies or approaches have been implemented and 
evaluated in pre-hospital and hospital contexts?  
 
 Papers included in the review reported on the use of 20 different risk stratification tools.  
 
These tools vary in terms of origin of development (public/private/academic), how the tools can be 
purchased/licensed for use, the variables used to populate the tool, how they can be adapted for use in 
local contexts and how results can be accessed and manipulated by end users.  
 
 We are aware of the existence of considerably more risk stratification tools than were 
reported in the evaluation literature, suggesting that while risk stratification tools have been 
developed and used widely, there has been little reported evaluation of how they are 
implemented in real-world settings. 
 
We found eight papers reporting outcomes-based evaluations, six of which used randomised or cohort 
controlled study designs. Their purpose only partially overlapped with the core questions addressed in this 
review. These studies did provide evidence that: 
 
 The use of risk stratification tools in combination with a care management plan can improve 
patient outcomes.  
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 However, there is equivocal evidence to suggest that the use of a risk stratification tool just 
to determine eligibility for managed care has an added benefit. 
 
 The use of a risk stratification tool to determine components of a care management plan 
may contribute to reductions in hospital readmissions, health service use and improved 
patient outcomes.  
 
Evidence from evaluation in this area is scattered yet rapidly emerging. We found protocols of four high 
potential trials of the implementation of risk stratification tools that are due to report within the next 12 
months; all of which intend to take a comprehensive, mixed-methods approach to examining a broad range 
of aspects related to the implementation of risk stratification tools closely aligned to the objectives of this 
review.  
 
 The ACI may wish to consider an update of this review at a future date when the results of 
these studies become available.  
 
Question 2: Of these strategies or approaches, what key factors have been identified as critical 
enablers and/or barriers to successful implementation at a system level? 
 
Evidence of critical enablers and barriers to successful implementation was weak and relied on descriptive 
case studies and qualitative studies. We identified four key areas of implementation in which there are 
critical enablers and/or barriers.  
 
1) The engagement of clinicians in tool implementation, refinement and end use 
 
 Clinicians who already had an understanding and sympathy for population health 
perspectives were the easiest to engage  
 
 Investment in education and training may increase clinician engagement 
 
 Clinicians are more likely to use a risk stratification tool if they are given some independence 
to access and use data from the tool 
 
 A system that blends the use of a risk stratification tool with clinical judgement may improve 
acceptance among clinicians 
 
 The introduction of a risk stratification tool can lead to quite different patterns of patient 
flow. Existing systems (and staff) can be overwhelmed without careful planning. 
 
2) The context in which the tool was introduced into the health care system 
 
 Introducing a risk stratification tool within a clearly articulated broader strategy with two-
way communication between planners and healthcare providers can facilitate success. 
Related initiatives should be developed in parallel 
 
  
 
IMPLEMENTING SYSTEM-WIDE RISK STRATIFICATION APPROACHES | SAX INSTITUTE 8 
 Some examples of successful implementation could be characterised as ‘top-down’ with 
centralised data collection, distribution and funding 
 
 The wider operating environment can act as a barrier or facilitator to success; factors include 
incentives in other parts of the health care system that might encourage/discourage different 
models of care.  
 
3) Data requirements and characteristics of the tool 
 
 Commissioners have the option to develop a new tool or purchase an existing tool and adapt 
it locally. There is no strong evidence to indicate which option is more cost-effective 
  
 Reliable up-to-date data is required to populate risk stratification tools 
 
 Linked, or preferably centralised, data collection systems facilitate prompt, accurate 
prediction 
 
 Tools that have been adapted to local contexts by using locally relevant indicators and 
having been validated locally may be more reliable. Tools developed in other countries may 
over- or under-predict risk when applied locally 
 
 Some tools that are intended to be populated with clinical data gathered directly from the 
patient can be adapted for use with administrative data. 
 
4) Equity issues 
 
 The collection and linkage of patient data requires strong data protection systems. Data 
protection laws and regulations increase the complexity of the environment in which risk 
stratification tools are implemented 
 
 More targeted ‘impactibility’ models (that identify patients who may benefit most from a 
particular intervention) are contentious and rarely debated in the literature. Some 
jurisdictions have rejected this approach on equity grounds. 
 
Question 3: How were these models adjusted or adapted during or after evaluation to take into 
account critical enablers and barriers? 
 
Changes during implementation or after evaluation were rarely discussed in the identified studies. 
Evidence is primarily from descriptive case studies only and therefore weak.  
 
 In some jurisdictions the predictive accuracy of an ‘off the shelf’ risk stratification tool was 
found wanting when applied in local contexts. Tools were adapted using locally relevant 
indicators and validated locally 
 
 Most tools are re-calibrated on a regular basis (every 2−4 years) 
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 In some jurisdictions, the introduction of training and information packages for clinicians 
increased engagement with, and acceptance of, a risk stratification tool  
 
 In some jurisdictions, the implementation of the tool was changed to formally include clinical 
judgement in the decision-making process, either at the point of decision to treat, or by 
establishing new criteria for inclusion/exclusion through surveying clinicians’ opinions 
 
 The mechanism through which tool outputs are distributed to clinicians has evolved. In early 
approaches data was sent to clinicians via email or mail, resulting in a time-lag. More 
recently clinicians can access tool outputs through secure web-based user interfaces 
 
 The frequency at which risk stratification algorithms tend to be run has evolved from 
periodic (six-monthly, monthly) to continual.  
 
Question 4: What key learnings are to be derived from implementing strategies or approaches to risk 
stratification, from a system-wide perspective? 
 
Despite the lack of strong studies – and the dearth of Australian evaluations of risk stratification tools, some 
learning points can be extracted that are relevant to the NSW context. 
 
 A key decision in the approach to risk stratification is to decide between purchasing a ready-
made commercial risk stratification tool or developing a new one. The literature 
demonstrates some of the benefits of starting afresh, especially in developing around local 
data sources and problems. The pitfalls are also clear, mainly around workforce and cost 
 
 The design of a new tool or adaptation of a ready-made one will depend on ready availability 
of relevant linked data, minimal expenditures and labour to link incompatible systems 
 
 The risk stratification programs which met greatest acceptance and fewer teething problems 
were embedded in clearly explained broader disease management and care integration 
strategies 
 
 The risk stratification tools that won swiftest support from clinicians were designed with 
user-friendly portals so that health practitioners and, where possible, patients could access 
useful information, often linked to decision aids relevant to the patient’s risk 
 
 Data protection and privacy issues need to be sorted out very early 
 
 Health care practitioners were more likely to embrace new methods of case finding if they 
were consulted at every stage. If they could see a clear benefit to their own patients, they 
were much more prepared to make some of the changes in practice required and less likely 
to see risk stratification tools as an attack on clinical judgement 
 
 Considering the lack of publicly available information on the implementation of risk 
stratification tools in real-world settings, any adoption of such an approach in NSW should 
include rigorous evaluation.  
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2  Background 
This review has been commissioned by the New South Wales Agency for Clinical Innovation (ACI) and the 
Sax Institute to inform decisions on the development or adoption of risk stratification tools for potential 
application in NSW.  
 
The focus of this review (which will complement others) is the implementation of risk stratification tools.  
Risk stratification models are used for predicting events such as unplanned hospital admissions, which are 
undesirable, costly and potentially preventable. Risk stratification is central to linking people identified at the 
highest risk of health deterioration to the most appropriate evidence-based integrated care strategies.  
 
The primary aim of the review is to identify the major issues that arise in implementation, how these have 
been addressed, and to understand their relevance and potential applicability in the NSW context. The 
review is intended to identify critical enablers and barriers to implementation from a system-wide 
perspective, for consideration in a NSW risk stratification plan. 
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3  Review questions 
1. What system-wide risk prediction strategies or approaches have been implemented and evaluated in 
pre-hospital and hospital contexts?  
 
2. Of these strategies or approaches, what key factors have been identified as critical enablers and/or 
barriers to successful implementation at a system level? 
 
3. How were these models adjusted or adapted during or after evaluation to take into account critical 
enablers and barriers? 
 
4. What key learnings are to be derived from implementing strategies or approaches to risk stratification, 
from a system-wide perspective? 
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4  Approach to the review 
We use the term ‘risk stratification tool’ to mean all models, tools and systems that use algorithms to predict 
future risk of health service utilisation. These algorithms include variables and equations designed to protect 
against the oversimplification and inaccuracy of simple threshold models, e.g. they take into account the 
problem of ‘regression-to-the-mean’, where high users of health services in any one given year tend not to 
be high users in the previous or following year.  
 
We presume some knowledge of stratification tools and the types of variables used to populate them. We 
therefore provide only limited information on the precise data required for each risk stratification tool and 
their predictive accuracy. Reports on the development and validation of virtually all of the tools reviewed 
here can be found in the peer-reviewed literature. 
 
To define the scope of the review in terms of the ‘implementation’ of risk stratification tools, we examined 
the spectrum of literature on risk stratification and determined the specific field of interest for this review 
(See Figure 1). 
 
Papers that studied or described the adaption of a standard risk stratification tool for a new context or the 
implementation of a new tool were of primary interest. Papers that focused on testing the predictive 
accuracy of a tool or the management of care following the use of the tool were only of interest if they also 
addressed adaptation or implementation. Papers that described care management following population risk 
stratification were only included if the use of the tool was sufficiently described as part of the 
intervention/case description. 
 
Figure 1: Spectrum of literature on risk stratification and area of interest for review 
 
 
 
Need for model 
Development of 
tool 
Validation and 
predictive 
accuracy testing 
Adaption of tool 
for new context 
Implementation 
of tool  
Managment of 
care based on 
outcomes of tool 
applicaton 
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5  Search methods 
Our search strategy followed a two-pronged approach. 
 
First, a systematic search was conducted in Medline (via OvidSP), Embase, Scopus, the Cochrane Library and 
CINAHL databases with the following search terms: 
 
Risk stratificat* OR Risk profil OR Population profil OR Population segment* OR Predictive risk OR Predict* 
model OR Risk predict* OR Risk Population* OR Risk model* OR Stratificat* strateg* 
AND   
Health service* OR Managed Care OR Integrated Care OR Primary Care OR Primary Health Care OR Aged 
Care OR Hospital OR Health System OR Population health  
AND  
Models OR Tools OR Program OR System 
 
Truncation was applied to capture various word endings and spellings. Subject headings were applied where 
available in the respective database and adjusted to interface-specific demands. Full citation searches were 
applied in preference to keyword/title where possible. Filters applied included publication date 2000−2015 
and available in English language. A complete list of search terms for each database is outlined in Appendix 
1. 
 
Database searches returned the following results: Medline 578 citations; Embase 646; Scopus 185, Cochrane 
Library 23 and CINAHL 707 producing a total of 2139 results. 
 
Second, focused searches were conducted in Medline, Embase, Google scholar, google and Medline for the 
following risk prediction models: “PARR”, “SPARRA”, “SPARRA-MH”, “Combined Predictive Risk Model” 
“Hospital Admission Risk Prediction”, “Adjusted Clinical Groups”, “LACE index”, “Prism”, “EARLI”, “Charlson 
Co-Morbidity”, “PEONY”, “OPTUM”, “Community Assessment Risk Screen (CARS)”, “Pra”, “PraPlus”, “Adjusted 
Clinical Groups”, “Krumholz Model”, “Qadmissions”, “Framingham calculator” “ANDROD”, “APACHE” “Risk 
Stratification Indices”, “Risk Quantification Index” 
 
This returned an additional 31 results.  
 
The total combined search results totalled 2170 citations that were downloaded to EndNote to be assessed 
for inclusion in the review. After removal of duplicates the total number of citations was 2107. 
 
A title and abstract search eliminated 2051 references and a full text assessment eliminated a further 22 
papers based on the following criteria: 
 
In alignment with the approach to the review outlined above, we included include papers that addressed: 
 
 Adaptation of a risk stratification tool for real world application 
 Implementation of a risk stratification tool. 
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We excluded papers that solely addressed: 
 
 Needs assessment or general potential applicability of risk stratification tools 
 Development of a tool 
 Validation of a tool/predictive accuracy testing 
 Care management following the use of risk stratification tools, but not the use of the tool itself 
 Risk predictive tools used exclusively within the hospital setting “on the wards”. 
 
We were aware that there would be few rigorous evaluations that assess the impact of implementation of 
risk stratification tools. We therefore conducted our search broadly to include: 
 
 Evaluations using control (randomised, pseudorandomised, cohort, historical), multiple baseline, 
and interrupted time series designs 
 Qualitative studies/surveys 
 Comparative case studies 
 Descriptive case studies/reports 
 Implementation guidelines 
 Study protocols 
 Reviews of models. 
 
We excluded: 
 
 Commentary 
 Newspaper and magazine articles 
 Powerpoint presentations 
 Abstracts 
 
Additional inclusion criteria were: 
 
 Implementation of tool in an OECD country 
 
A total of 30 papers and 4 protocols were found suitable for inclusion in the review including comparison 
controlled evaluations with various study designs, qualitative evaluations, comparative case studies and 
single descriptive case studies (See Appendix 3). We also found five reviews of tools and five 
implementation guides (see Assessment under Question 1). See Prisma flowchart in Appendix 2. 
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Table 1: Classification of papers included in review 
Type Papers Protocols 
Evaluations of use of tool and associated 
care/response using control, multiple baseline 
or interrupted time-series designs  
8 2 
Qualitative evaluations 4 1 
Comparative case studies 2 1 
Descriptive case studies 6  
 
Reviews of tools/brief multiple case studies 
5  
Implementation guides 5  
TOTAL 30 4 
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6  Question 1: 
What system-wide risk prediction strategies or 
approaches have been implemented and evaluated 
in pre-hospital and hospital contexts?  
Key findings 
 
 Papers and protocols included in the review reported on the use of 20 different risk 
stratification tools.  
 
These tools vary in terms of the origin of development (public/private/academic), how the tools can be 
purchased/licensed for use, the variables used to populate the tool, how they can be adapted for use in 
local contexts and how results can be accessed and manipulated by end users (See Table 2, page 26). 
 
 We are aware of considerably more risk stratification tools than were reported in the 
evaluation literature, suggesting that while risk stratification tools have been developed and 
used widely, there has been little published documentation on how they are implemented in 
real world settings. 
 
We found eight papers reporting outcomes-based evaluations, six of which used randomised or cohort 
controlled study designs. Their purpose only partially overlapped with the core questions addressed in this 
review. These studies did provide evidence that: 
 
 The use of risk stratification tools in combination with a care management plan can improve 
patient outcomes 
 
 However, there is equivocal evidence to suggest that the use of a risk stratification tool 
solely to determine eligibility for a managed care program has a positive effect on patient 
outcomes 
 
 The use of a risk stratification tool to determine components of a care management plan 
may contribute to reductions in hospital readmissions, health service use and improved 
patient outcomes.  
 
Evidence from evaluation in this area is scattered yet rapidly emerging. We found protocols of four high 
potential trials of the implementation of risk stratification tools that are due to report within the next 12 
months; (See Question 1 Assessment, page 23) all of which intend to take a comprehensive mixed-methods 
approach to examining a broad range of aspects related to the implementation of risk stratification tools 
closely aligned to the objectives of this review.  
  
 
17 IMPLEMENTING SYSTEM-WIDE RISK STRATIFICATION APPROACHES | SAX INSTITUTE 
 ACI may wish to consider an update of this review at a future date when the results of these 
studies become available.  
 
Overview 
 
We found a total of six evaluations using a control, one interrupted time-series evaluation and one multiple 
baseline evaluation, making a total of eight evaluations that measured the impact of implementing a risk 
stratification tool against quantifiable outcomes. We also found four qualitative evaluations, two 
comparative case studies and six descriptive case studies. Four protocols on mixed-methods evaluations 
were found. Papers and protocols included in the review reported on the use of 20 different risk 
stratification tools.  
 
Evaluation studies and tools 
 
Of the total of eight studies that measured the impact of implementing a risk stratification tool on 
quantifiable outcomes, only one study 
[1]
 used a control group that did not receive any risk stratification.  
 
 1248 patients with diabetes under the care of GPs in Hong Kong were randomly selected for 
participation in the study. Participants were matched by age, sex, and HbA1c level at baseline with a 
further 1248 patients as the usual care group. Patients in the intervention group were risk stratified 
using the Joint Asia Diabetes Evaluation (JADE) Risk Engine, a tool populated by clinical 
assessment (including BMI, waist circumference, BP, HbA1c, full lipid profile, renal function) and 
history of previous complications as ‘very high’, ‘high’, ‘medium’ and ‘low’ risk. [1] Different 
management strategies (such as nurse, consultant, allied health visits and a patient empowerment 
(education) program) were applied within the Risk Assessment and Management Program for 
Patients with Diabetes Mellitus (RAMP-DM) program according to each patient’s profile. At 12 
month follow up, the RAMP-DM group had significant net decrease in HbA1c, predicted CHD and 
stroke compared to the usual care group. 
 
In the remaining seven studies, which used a control, multiple baseline or interrupted time-series design, 
both the intervention and usual care groups were stratified using the adopted tool and only the managed 
care program after stratification comprised the intervention. Lessons from these studies therefore need to 
be interpreted carefully. Positive outcomes in the intervention group indicate benefits of implementing a 
managed care program that includes the use of a risk stratification tool, but cannot attribute results to 
either the care package or risk stratification tool alone.  
 
Amongst these studies, four 
[2‒5]
 involved interventions where the risk stratification tool was used solely to 
determine eligibility to receive a care package. In these studies there were either no, or only small, benefits 
for the intervention group over control groups.  
 
 In Nairn, Scotland, two cohorts of approximately 10,000 patients from two primary care practices 
with similar catchment and geographical characteristics were risk stratified using the Nairn Case 
Finder. 
[2]
 Two groups comprising 96 high-risk patients were matched for age, sex, multiple 
morbidity indexes, and secondary care outpatient and inpatient activity. Only patients from the 
intervention practice received an “Anticipatory Care Plan” comprising a case manager, allied health 
visits and a patient interview to identify unmet need. Results were presented pre-post and control 
compared. Mortality rates in the two cohorts were similar, but the hospital bed days used in the last 
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three months of life were significantly lower for the decedents with an Anticipatory Care Plan. 
 
 Medicare beneficiaries aged 70 and older in Ramsey County, Minnesota, USA were stratified using a 
self-completed Probability of Readmission (Pra) instrument survey received in the mail, resulting 
in a patient score between 0 (low risk) and 1 (highest risk). 
[3]
 All high-risk respondents (Pra >0.4) 
were telephoned to obtain baseline measurements. Patients were matched according to Pra 
stratification block and randomised. Primary care physicians for the control group were notified of 
their patients’ high risk for repeat hospitalisations and thereafter received care their physician 
deemed appropriate. Intervention group patients received an interdisciplinary care package that 
included access to a geriatrician, nurse practitioner and a 24-hour on-call service. Mortality, use of 
health care services, and total Medicare payments did not differ significantly between the two 
groups. Follow up interviews found that patients in the intervention group were significantly less 
likely to lose functional ability. 
 
 High-risk patients identified using the LACE (Length of Stay, Acuity of admission, Comorbidities, 
Emergency department visits) tool administered at discharge in four hospitals in the Toronto 
Central Local Health Integration Network 
[4]
 were randomly allocated to either admission to a 
Virtual Ward or usual care. Patients assigned to a Virtual Ward received telephone follow-up, home 
visits or clinic visits. An inter-professional team met daily at a central site to discuss management 
plans. Usual care involved a structured discharge summary, counselling from the resident physician, 
and arrangements for home care as needed. There was no statistically significant difference 
between the groups on 30 day, 60 day, six month or one year readmission. 
 
 Eight community-based primary care practices in Baltimore, MD and Washington DC, USA 
participated in the Guided Care program study 
[5]
. Patients of the participating physicians were 
selected for initial screening according to age (>65) and type of insurance coverage. The 
Hierarchical Condition Category (HCC) was applied using administrative data. Patients were 
potentially eligible if their HCC risk ratios were in the highest quartile of the population of older 
patients covered by their health care insurer. Usual care was given to 419 patients and 485 patients 
received a Guided Care package comprising eight nurse-led services. In intention-to-treat analyses, 
Guided Care did not significantly improve participants’ functional health, but it was associated with 
significantly higher participant ratings of the quality of care. 
 
Three studies 
[6-8]
 involved interventions where the risk stratification tool informed not only eligibility to 
receive a managed care package, but also the content of that package. These studies reported some 
improvements in hospital readmission rates.  
 
 Kaiser Permanente Southern California (KPSC) used the LACE tool to stratify patients into low (LACE 
score 0-6), medium (LACE score 7-10) and high (LACE score 8 -11) risk. 
[6] 
Different bundles of care 
forming part of the “Transition in Care” program were offered to patients accordingly with low-risk 
patients receiving 1) a standardised discharge summary including the tool result; 2) medication 
reconciliation and 3) access to a transition hotline. Medium-risk patients had, in addition to the 
interventions above, access to a post hospital visit from a physician within 14 days and high-risk 
patients within seven days. High-risk patients also received a follow-up call within 72 hours from 
discharge; a palliative care consult (if needed) and a complex case conference.  
The program was implemented in all 13 KPSC medical centres which collectively discharge 
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approximately 40,000 patients on medical risk plans each year. The intervention was introduced in 
all centres in the first quarter of 2012. Readmission rates from December 2010 to November 2012 
decreased from approximately 1.0 to 0.80 and 12.8% to 11%, respectively.  
In this study, LACE was first tested for its applicability and predictive ability with a retrospective 
study applying it to 30,000 KPSC Health Plan discharges over a 12-month period. To ease 
implementation, the LACE calculator was made available on the KPSC Electronic Medical Record 
and was automatically included in each patient’s daily note and discharge summary. 
 
 For the Indiana Chronic Disease Management Program (ICDMP), automated queries of Medicaid 
claims were created to identify people with diabetes and CHF based on ICD-9 or disease specific 
prescriptions in the previous 12 months. 
[8] 
The patient lists were sorted by practice location and 
county. Eligible participants were informed by mail. A purposefully developed risk stratification 
tool (ICDMP tool) was used to assign participants to different program services (nurse care 
managers to highest risk 20%; telephone care coordinators to remaining 80%). The Regenstrief 
Institute (academically affiliated research organisation) was engaged to develop the risk 
stratification tool with an algorithm based on two years of retrospective claims data using three 
predictors 1) total net Medicaid claims in past 12 months; Medicaid aid category (eg. 'aged' or 
'disabled'); total number of unique medications filled in past year. Based on the phased 
implementation of the program in three regions of the state (Central Indiana in July 2003, Northern 
Indiana in July 2004 and Southern Indiana October 2004), 14 repeated cohorts of Medicaid 
members were drawn over a period of 3.5 years and the trends in claims were evaluated using a 
repeated measures model. The evaluation found a flattening of cost trends between the pre- and 
post-ICDMP initiation periods and remained flat in the final year of follow up. 
 
 A purposefully developed risk stratification tool based on the American Diabetes Association 
Clinical Practice recommendations (henceforth ADACP tool) was implemented as part of a trial of a 
comprehensive diabetes program within a managed care organisation (MCO) in the US. 
[7]
 Adults 
with diabetes mellitus enrolled in two clinics (N=740, 370 in each clinic) received the intervention. 
Data from 623 members at a third clinic acted as a control group. Patients were stratified into high-, 
moderate-, or low-risk groups within disease categories. Interventions were based on previously 
agreed-upon standing orders (protocols) after approval from the primary care physician. Clinical 
outcomes as well as patient satisfaction (questionnaire) were measured at baseline and 12 months. 
Significant improvements were found in the intervention groups for glycaemic control and patient 
satisfaction as well as compliance with treatment protocols.  
 
We found that the controlled or longitudinal studies described above offered no conclusive evidence of the 
benefits or limitations of implementing risk stratification tools in real-world situations. However the use of 
risk stratification tools in combination with a care management plan may offer some patient outcome 
benefits. The use of a risk stratification tool to determine components of a care management plan may 
contribute to reductions in hospital readmissions, health service use and improved patient outcomes.  
We found four qualitative evaluations of the implementation of risk stratification tools. 
[9-12]
 These studies 
aimed to provide specific insights into factors influencing successful implementation of risk stratification 
tools by researching the experiences of end users. While the level of evidence is weak, they uncovered high 
promise indicators of real world barriers and facilitators to successful implementation.  
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 In the Basque Country, Spain, an adapted risk stratification tool based on the Johns Hopkins 
University Adjusted Clinical Groups (JHUACG) model was introduced in several primary care 
practices. 
[9]
 Three focus groups were conducted exploring clinicians’ opinions and experiences 
related to the tool and its implementation in their daily practice. A purposive sample of 12 GPs and 
11 primary care nurses participated in the groups. The study identified several enablers and 
challenges to implementation and the need to frame the implementation of a new risk stratification 
tool within a wider strategy (see Review Question 2).  
 
 The Case Smart Suite Germany (CSSG) risk stratification tool was used in a cohort of patients 
insured with the German General Regional Health Fund (AOK) and registered at one of 10 small to 
mid-sized primary care practices in Munich, Germany to select patients for a managed care scheme. 
[10]
 Twelve primary care physicians were asked to identify 30 patients from the same cohort for 
inclusion in the same scheme. The primary care physicians (PCPs) were given the opportunity to 
compare their own selection with that of the risk stratification tool before engaging in a semi-
structured interview on how primary care physicians experienced the use of CSSG compared with 
using clinical judgement. Overall, PCPs rated the approach as a useful tool to identify patients likely 
to benefit from case management. However, they were concerned about time lags between data 
analysis and patient recruitment. 
 
 The evaluation of the use of the Prism tool in Demonstrator Sites for the Wales NHS Chronic 
Disease Management Program sought to identify the health and social care staff using or otherwise 
engaging with PRISM and its outputs; describe the ways in which Prism has been used and gather 
views on current and potential use of the tool at practice and population levels.
 [11]
 Focus groups 
and interviews were undertaken with staff in the 13 general practices taking part in the 
demonstrator testing of Prism, including locality planning coordinators and GP leads. The study 
found that first impressions of Prism were mixed and often improved following further exposure to 
the tool. Various enablers and barriers were identified (See Review Question 2).  
 
 Scottish Patients at Risk of Readmission and Admission (SPARRA) is a risk prediction tool 
implemented for the whole of the Scottish population to predict an individual’s risk of being 
admitted to hospital as an emergency inpatient within the following year. 
[12]
 In 2008, NHS 
Scotland’s Information Services Division that developed and has carriage of the tool undertook a 
qualitative survey of tool users at Community Health Partnerships (CHPs), Health Board, and GP 
level. Twenty five survey respondents (83% response rate) reported on: 1) Individuals to whom 
SPARRA data is forwarded, 2) local modifications to the output, 3) local additions to the output, 4) 
data sharing protocols in place, 5) local uses of SPARRA data and 6) suggested additional 
data/information to be included in the SPARRA output. The study found that patterns of 
dissemination were variable and complex and in some instances data was not actually reaching 
intended end users. The study found that end users were interpreting SPARRA data correctly and 
making suitable adjustments. Prescribing data was identified as highly desirable to augment the 
current SPARRA methodology and the study found improvements in functionality of SPARRA would 
be desirable to allow end users to filter or highlight patient groups of specific interest (see Review 
Question 2). 
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The qualitative evaluations above provide no conclusive evidence of the most critical barriers or enablers to 
intervention as they apply to any one particular tool. However, they do highlight potential issues for 
consideration in the NSW context (See Review Question 2 and 4).  
 
We identified two comparative case studies of implementation of risk stratification tools. In these studies 
certain differences in the implementation of the tool are compared across localities and considered for 
possible effect on differences in uptake, acceptance, sustainability and outcomes. The level of evidence 
produced is weak due to the risk of confounding factors across case study contexts. Nevertheless 
comparative case studies offer insights into the potential implications of different contexts and 
implementation practices.  
 
 Three adaptations of the “Virtual Wards” program in Croydon, Devon and Wandsworth, UK used 
stratification tools to determine catchment areas for Virtual Wards and select patients for 
admission. 
[13]
 The Combined Predictive Risk Model was used in Croydon, where programs had 
already been implemented using GP data to improve care. An adapted version with a new user 
interface was created for use in Devon (henceforth the Devon Combined Predictive Model) and 
the PARR model was used in Wandsworth. In Croydon the program was fully funded through the 
Primary Care Trust while in the other two cases the program was co-funded with the local council. 
The nature of the Virtual Ward program differed in terms of composition of the multidisciplinary 
team, leading Virtual Ward staff (community matrons, ward clerks, ward GP) and timing of 
implementation. The study compared the operating environment, organisational culture, the extent 
to which ‘activated patients’ were encouraged, culture of integration/GP involvement, data sharing 
and program champions. The study identified a number of barriers and enablers to implementation 
in each case (See question 2). 
 
 The three cases described above are also included in a comparative review of six managed care 
programs including North Somerset UK (using no risk stratification tool), Toronto Canada (using the 
LACE tool) and New York City USA (using a purpose build Medicaid data model for their 
“Hospital2Home” scheme). [14] The managed care schemes varied in terms of the composition of 
multidisciplinary teams, role and discipline of ward coordinators, (eg. In New York the case 
managers came from the social sector due to housing problems of a large number of the patients), 
and the size of the ‘ward’. The implementation of the risk stratification tool differed in terms of 
whether a predictive model was used at all; whether an impactibility scale was used to further 
identify patients most likely to benefit from care (eg. Hospital2Home, New York) and the extent to 
which a predictive model was used to discharge patients from the Virtual Ward (Devon, Croydon).  
 
We identified six papers reporting descriptive case studies of risk stratification tools implemented in real-
world settings. Although the strength of evidence emerging from these case studies is weak, they offer the 
richest insight into the range of factors that were perceived to enable or facilitate successful implementation 
of risk stratification tools. In some cases, the descriptive case studies offered in depth insights into how risk 
stratification tools were implemented in the controlled/comparative studies outlined above. We outline 
these case studies briefly below.  
 
 Challenges to the implementation of the ‘Virtual Ward’ model of managed care described above 
are outlined in a case study by Lewis et al. 
[15]
 The two main challenges outlined include the 
reluctance of some GPs to allow patients to be selected purely on the basis of a predictive risk 
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model (Combined Predictive Risk Model or PARR), and the request by some for the right to 
select which patients should be offered admission. In response, a series of presentations to GPs set 
out the evidence base for predictive models, in particular, findings from a literature review 
(conducted by The King’s Fund for the Department of Health) that suggested that predictive 
models could be more accurate than clinical opinion in forecasting risk of future hospitalisation. 
The second challenge identified was in communicating the Virtual Ward concept to community-
based staff; staff initially found the concept was somewhat abstract and difficult to grasp. 
 
 The systemic coronary risk evaluation (SCORE) tool was applied to risk stratify 1011 patients 
living in Cyprus, diagnosed with diabetes mellitus, hypertension or hyperlipidaemia 
[16]
. The results 
of the stratification were used to assess the quality of care for patients with these conditions in the 
country and inform new care policy decisions. Suboptimal control and under-treatment of patients 
with cardiovascular risk factors were found, as well as under-prescription of antihypertensive drugs, 
lipid-lowering drugs and aspirin for all three high-risk groups. Improvement of documentation of 
clinical information in the medical records as well as GP training for implementation and adherence 
to clinical practice guidelines were recommended as potential areas for further discussion and 
research.  
 
 Rosenman et al. describe the implementation of the purposefully built risk stratification tool in the 
Indiana Chronic Disease Management Program (ICDMP tool) mentioned above 
[17]
. The algorithm 
was developed based on two years of retrospective Medicaid claims data and used three predictors: 
total net Medicaid claims in past 12 months; Medicaid aid category (eg. 'aged' or 'disabled') and 
total number of unique medications filled in past year. The Indiana state Medicaid agency 
commissioned development of the tool to the same vendor that provided a medical records system 
for a large urban group practice within the state (Regenstrief). Consultation with end users 
informed the development of the tool. Automated queries are run every 3−6 months to identify 
eligible patients, with notifications going directly to patients in the mail. Patients entering the 
program are then risk stratified to assign participants to different program services (nurse care 
managers to highest risk 20%; telephone care coordinators to the remaining 80%).  
 
 Clalit Health Services (Israel’s largest managed care organisation) sought to adapt the Johns 
Hopkins University Adjusted Clinical Groups (JHUACG) risk model for implementation to select 
patients for a multi-morbid care management program. 
[18]
 Six physicians were surveyed on 
characteristics of their current (2012) patients to elicit clinical considerations for high-risk patient 
identification. Separately the JHUACG tool was used to risk stratify patients from 2010-2011 using 
data from the Clalit Health Services central administrative data set. Clinically-defined exclusion 
criteria obtained from the physician survey were used to revise the final list of patients to receive a 
care management program.  
 
 In Valencia, Spain, the Pra and Community Assessment Risk Screen (CARS) tools were used to 
detect patients at risk of hospital readmission in a sample of 500 elderly people (65+) from the VHS 
in Spain. 
[19]
 Both of these tools, when used off-the-shelf, were designed to be fulfilled either by 
post or telephone interview (Pra) or by interview with medical staff (CARS). The Valencia health 
service trialled using administrative data to populate the tools, supplemented by two self-report 
items in the case of the Pra tool. Both tools implemented this way were found to have an 
acceptable level of accuracy in the prediction of hospital admissions. 
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 The Geisinger Clinic, comprising 40 community-based primary care practices in Pennsylvania, 
undertook a feasibility test of the use of the Framingham Risk Score (FRS) to risk-stratify patients 
and involve them in shared decision making
. [20]
 Patient-reported data was obtained via a 
touchscreen device-administered questionnaire in the practice and was automatically combined 
with electronic health record (EHR) data to calculate risk. Higher-risk patients viewed an interactive 
web-based tool and chose treatment options to modify risk factors. A real-time simulation 
indicated directly to patients their expected outcomes when the treatment option was followed. 
Following a trial period during which 1068 patients used the device, the system was considered 
feasible for full implementation. The Framingham Risk Score was modified for final use (two 
variables added −alcohol use and family history, two variables changed from binary to continuous 
measurement − smoking and diabetes, and one variable omitted − left ventricular hypertrophy 
(LVH) on electrocardiogram). The modified FRS was used to calculate both the absolute 10-year risk 
and an associated relative risk of a cardiac event for risk stratifıcation.  
 
Assessment 
 
We are aware of the existence of considerably more risk stratification tools than were reported in the 
evaluation literature described above. This suggests that while risk stratification tools have been developed 
and used widely, there has been little reported evaluation of how they are implemented in real-world 
settings. The literature on the development and validation (for predictive accuracy) of risk stratification tools 
is considerably more abundant but outside of the scope of this review.  
 
While we found eight papers reporting outcomes-based evaluations, six of which used randomised, 
matched or cohort controlled study designs (NHMRC levels II and III-2), 
[21]
 their purpose only partially 
overlapped with the core questions addressed in this review. While we only included studies that provided 
some information on context and implementation of the risk stratification tool, this was not the main 
subject of investigation. This diminished relevance, or ‘indirectness’ [22] means that these studies contribute 
only a limited understanding to what contributes to successful implementation of risk stratification tools in 
real-world settings and critical enablers and barriers.  
 
These studies do provide evidence that the use of risk stratification tools in combination with a care 
management plan may offer some patient outcome benefits and that the use of a risk stratification tool to 
determine components of a care management plan may contribute to reductions in hospital readmissions, 
health service use and improved patient outcomes. There is equivocal evidence to suggest that the use of a 
risk stratification tool solely for determining eligibility for managed care has a positive effect on patient 
outcomes.  
 
Evidence from qualitative studies and descriptive case studies identify a range of factors that contribute to 
successful implementation. Despite a weaker study design (unclassified in traditional evidence hierarchies 
such as that from the NHMRC) they provide the most promising evidence for this review to answer 
questions of barriers and enablers to successful implementation of risk stratification tools in the real world. 
They are therefore heavily drawn upon to respond to Review Questions 2 and 3.  
 
Due to the small number of qualitative and case study papers found, we also draw lessons from an 
additional two types of papers in the remaining sections of this rapid review.  
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Five risk stratification tool implementation guides intended for Medicaid purchasers in the USA,
[23]
 
Commissioners in NHS England (two guides), 
[24, 25]
 Prism end users in Wales 
[26]
 and SPARRA end users in 
Scotland 
[12]
 were identified during the focused search. These guides only give an indication of the intended 
implementation process of various tools and thus do not provide quality evidence; however they do specify 
conditions for implementation that may be considered important enablers/barriers. 
 
We also found five general reviews of the role of predictive risk stratification tools in healthcare and their 
intended use. 
[27-31]
These reviews are not systematic reviews of controlled studies and do not provide a 
higher level of evidence than the articles described above. However, they do contain brief case studies, 
overviews of the predictive ability of various tools and policy-level analysis of key considerations when 
promoting and/or mandating the use of risk stratification tools.  
 
Finally, we found that evidence from evaluation in this area is scattered yet rapidly emerging. We found 
protocols of four high potential trials of the implementation of risk stratification tools that are due to report 
within the next 12 months; all of which intend to take a comprehensive mixed-methods approach to 
examining a broad range of aspects related to the implementation of risk stratification tools closely aligned 
to the objectives of this review. The ACI may wish to consider an update of this review at a future date when 
the results of these studies become available.  
 
 The PRISMATIC trial is currently underway led by the Centre for Health Information Research and 
Evaluation (CHIRL) at Swansea University, UK. 
[32]
 This trial will evaluate the implementation of the 
Prism risk stratification tool throughout Wales, UK. Primary care practices will receive access to the 
Prism tool and training randomly, and thereafter be able to use Prism with clinical and technical 
support. Costs, processes of care, satisfaction and outcomes at baseline, six and 18 months, using 
routine data and postal questionnaires will be assessed. Focus groups and interviews are being 
undertaken to elucidate experiences of using the by practitioners and policy makers. The 18-month 
intervention period has been completed and reporting is expected in 2015. 
 
 The Diabetes Population Risk Tool (DPortT) predicts nine-year risk for diabetes and is being 
implemented in Ontario and Manitoba in Canada. 
[33]
 Predictive factors included are body mass 
index, age, ethnicity, hypertension, immigrant status, smoking, education status and heart disease. 
The planned evaluation will assess the effectiveness and impact of a proposed Knowledge-to-
Action framework for facilitating the implementation of the tool and use observer notes, interviews 
and surveys to identify factors that facilitate uptake and overcome barriers to DPoRT use. 
 
 The INTEGRATE study 
[34]
 will assess the use of the Finnish Diabetes Risk Score (FINDRISC) tool as 
part of the Personalized Prevention Approach for CardioMetabolic Risk (PPA CMR) scheme. The 
scheme will be offered in 40 general practices in the Netherlands, making up a representative 
sample of all Dutch general practices with regard to the distribution in rural/urban and solo/group 
practices. After an online risk estimation, patients with a score above the risk threshold will be 
offered detailed risk profiling and tailored care management. Lifestyle, health and work status will 
be measured at baseline and after 12 months. 
 
 A European wide project, “Activation of Stratification Strategies and Results of the 
interventions on frail patients of Healthcare Services (ASSEHS)”, has been established to assess 
the use of existing health risk stratification strategies and tools throughout Europe. 
[35]
 Multiple 
studies are anticipated with the first mapping the implementation stages of six risk stratification 
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tools used in Europe. First results are expected in 2015. Further work packages include the 
development of a consolidated standard for appraising stratification techniques; analysis of the 
feasibility of introducing stratification tools in healthcare including identifying barriers and 
facilitators; measuring impact of stratification tools on structure and processes of healthcare 
organisations; assessing impact of using stratification strategies and tools on health service 
resources, management and clinical practice, involving different health services and social actors, 
and primary and secondary care. 
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Table 2: Risk stratification tools evaluated in the review literature 
Risk stratification 
tool 
Studies Developer/origin Input data and implementation 
Case Smart Suite 
Germany (CSSG)  
Freund (2012) Commercial 
developer. Verisk 
Health, Munich, 
Germany.  
This tool may be purchased for use ‘off-the-shelf’ by 
healthcare providers and insurers. The algorithm used is 
similar to that of diagnostic cost groups. Inputs include ICD-
10-German Modification (GM) diagnosis codes assigned in 
outpatient and inpatient settings, prior costs, hospital 
admissions and demographic data. Clinically similar ICD-10-
GM codes are classified into diagnostic groups that are 
collapsed into diagnostic categories. [36] Generic models for 
adaptation in other countries are also available for purchase.  
Combined Predictive 
Risk Model (CPRM) 
Lewis (2010); 
Lewis (2013); 
Lewis (2012) 
Publicly developed 
tool (Kings Fund UK 
and Health Dialog). 
Now de-
commissioned.  
An algorithm for predicting re-hospitalisation in the next 12 
months intended for use by Primary Care Trusts and other 
NHS organisations in the UK where both primary and 
secondary data are available. Available for use by NHS 
organisations as a stand-alone string code; requiring the local 
build of a user interface. Allows segmentation of an entire 
NHS population (all patients registered with a GP) into 
relative risk segments.  
Community 
Assessment Risk 
Screen (CARS) 
Doñate-
Martínez 
(2001) 
 This tool uses three variables to predict future 
hospitalisations: 1) pre-existing chronic diseases; 2) the 
number of prescription medications and 3) hospitalisations or 
ED use in the preceding 6–12 months. The score (0−9) is 
accumulative depending on the number or risk factors 
present. Data is obtained by medical staff directly from 
patients and the algorithm applied. In Valencia, the tool was 
adapted for use with administrative data. [37] 
Diabetes Population 
Risk Tool (DPortT)  
Rosella (2014) Public tool 
developed by 
Canadian Institutes 
of Health Research 
and the Population 
Health 
Improvement 
Research Network 
Calculates the future risk of diabetes, for diabetes-free 
individuals. Uses publicly available national population health 
surveys administered by Statistics Canada (Canadian 
Community Health Survey). Publicly available for download 
directly into SAS statistics software or as a formula. Can be 
used to predict cases or to attribute the contribution of 
specific risk factors (included in the algorithm) to population 
risk. 
Devon Combined 
Predictive Model 
Lewis (2012); 
Lewis (2013) 
Adaptation of CPRM 
tool developed by 
NHS Devon, UK. 
Predicts unplanned admission to hospital or an emergency 
re-admission in the following 12 months. This adaptation of 
CPRM added seven local factors as variables including length 
of registration with GP.  
FINDRISC (Finnish 
Diabetes Risk Score) 
Badenbroek 
(2014) 
Publicly available 
tool developed in 
the Diabetes 
Prevention Unit, 
Department of 
Chronic Disease 
Prevention, National 
Institute for Health 
and Welfare, 
Helsinki, Finland 
Questionnaire style risk stratification tool available for use or 
adaptation online. [38] Assesses an individual’s risk of 
developing type 2 diabetes stratified as low, slightly elevated, 
moderate, high and very high. Included variables are: age, 
BMI, waist circumference, physical activity levels, 
consumption of vegetables, fruits or berries, high blood 
pressure requiring treatment, previous high blood glucose 
and family history.  
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Risk stratification 
tool 
Studies Developer/origin Input data and implementation 
Framingham Risk 
Score (FRS)  
Jones, Shah, 
Bruce et al. 
(2011) 
Developed as part 
of the Framingham 
Heart Study, Boston 
University. 
Algorithm publicly 
available.  
The updated version of this algorithm (from 2002) uses eight 
variables to assess risk of developing cardiovascular disease 
in the next 10 years. Variable thresholds are calculated 
differently for men and women. The tool is open source and 
may be integrated into clinical decision support tools, other 
multi-faceted risk prediction tools or completed online for 
real time results using one of several user interfaces available 
online. Has been shown to overestimate risk when applied to 
patients in European settings.  
Hierarchical Condition 
Category (HCC)  
Boult (2013) Developed by and 
for the Centres for 
Medicare and 
Medicaid Services, 
USA. 
Measures the burden of 70 disease categories that are 
correlated to diagnosis codes. Introduced in 2004 in the 
Medicare and Medicaid systems as the basis for capitation 
and reimbursements. The HCC for each patient is captured 
every 12 months and forms the basis of payments for the 
following 12 months. 
Johns Hopkins 
University Adjusted 
Clinical Groups  
Cohen, Flaks-
Manov, Low 
et al. (2015); 
Arce, De 
Ormijana,  
Orueta, et al. 
(2014) 
Developed at Johns 
Hopkins University 
with commercial 
licence rights.  
 Software package available for US or international licence 
(currently available Version 9). Uses various inputs that can be 
adjusted according to setting such as: age, gender, total 
disease burden, medical conditions, population markers, 
resource use and medications. Available as a stand-alone 
product or a part of a service delivery package and electronic 
medical record administration.  
Joint Asia Diabetes 
Evaluation (JADE) Risk 
Engine 
Jiao, Fung, 
Wong et al. 
(2014) 
Privately developed 
tool: Asia Diabetes 
Foundation and the 
Chinese University 
of Hong Kong.  
A risk stratification tool that forms part of a web-based portal 
of care protocols, clinical decision and self-management 
support. Patients consent to enrolment in the program, from 
which point medical data are carried within the portal. A 
yearly health assessment is carried out and data entered into 
the portal which is cross-matched with administrative data to 
measure risk of five-year probability of major clinical events. 
The full program is accessed by GPs through a secure web 
portal and key patient data are available for viewing at care 
appointments.  
LACE 
 
Dhalla, Lewis 
2012; Tuso, 
Huynh, 
Garofalo 
(2013) 
Publicly developed 
in Ontario, Canada.  
Data inputs are length of stay (“L”); acuity of the admission 
(“A”); comorbidity of the patient (measured with the Charlson 
Comorbidity Index score) (“C”); and emergency department 
use (measured as the number of visits in the six months 
before admission) (“E”). Intended to be administered within 
the hospital at the point of discharge.  
Nairn Case Finder Baker A, Leak 
P, Ritchie LD 
et al (2012) 
Public developer. 
NHS Scotland 
Highland Health 
Board 
Tool originally developed for Lodgehill Clinic in Nairn and 
measures risk of an unplanned admission to hospital in the 
subsequent 12 months. Primary care data are taken from the 
country-wide GP medical records system “General Practice 
Administration System for Scotland” (since changed for use 
with current system “GP Vision”). Primary care variables 
include age, sex, and chronic disease status. Secondary care 
data were taken from the NHS Highland Patient 
Administration System and include outpatient attendance 
and unplanned admission to hospital in the previous two 
years. The tool was run monthly and GPs were provided with 
lists of at risk patients. 
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Risk stratification 
tool 
Studies Developer/origin Input data and implementation 
PARR (Patients at Risk 
of Readmission) 
Lewis (2012); 
Lewis (2013) 
Publicly developed 
tool (Kings Fund UK 
and Health Dialog). 
Now de-
commissioned. 
Public risk stratification tool intended to be used by Primary 
Care Trusts in the UK. Produces a patient ‘risk score’ showing 
a patient’s likelihood of re-hospitalisation within the next 12 
months. Risk scores range from 0–100, with 100 being the 
highest risk. PARR1 uses data on prior hospitalisations for 
certain ‘reference conditions’ to predict risk of re-
hospitalisation while PARR2 uses data on any prior 
hospitalisation to predict risk of re-hospitalisation. Further 
iterations of PARR (including PARR-30) were developed. The 
tool originally did not come with an in-built user interface, 
although two have been developed (PARR + and PARR ++.)  
Prism Hutchings, 
Evans, 
Fitzsimmons 
(2013); 
Kingston: 
2010; 
Smallcombe, 
Burge-Jones 
(2013).  
Public tool 
commissioned by 
NHS Wales 
Informatics Service 
from King’s Fund 
and Health Dialog. 
Uses 22 variables from GP systems, eight from hospital 
inpatient record, three demographic variables, data of 
outpatient visits following ED visits and the Welsh Index of 
Multiple Deprivation to identify likelihood of an emergency 
hospital admission over the next 12 months. Both absolute 
risk (four risk levels based on percentage risk score) and 
relative risk (four risk levels based on risk score relative to the 
practice population) are measured. Care providers register for 
access and use Prism through a password-protected website. 
End users can view population level trends, view patient risk 
data (by entering a NHS number) or filter populations by risk 
level or other criteria.  
Probability of 
Readmission (Pra) 
Donate-
Martinez; 
Boult (2001) 
Developed at 
University of 
Minnesota. Johns 
Hopkins University 
holds exclusive 
rights from the 
University of 
Minnesota 
to sublicense to 
others. 
 Estimates probability of hospital readmission within four 
years. Inputs include age, gender, poor self-rated general 
health, availability of an informal caregiver, having ever had 
coronary artery disease, having had diabetes mellitus during 
the previous year, a hospital admission during the previous 
year, more than six doctor visits during the previous year. A 
more recent version of the tool (PraPlus) also includes 
questions about medical conditions, functional ability, living 
circumstances, nutrition and depression. Widely used in the 
USA. Use of the instruments must be under licence.  
 
Systemic coronary risk 
evaluation (SCORE)  
Zachariadou, 
Stoffers, 
Christophi et 
al. (2008) 
Developed by a 
consortium of 
researchers for 
European Society of 
Cardiology funded 
by European Union 
BIOMED program 
Developed in response to studies finding over-estimation of 
risk for CVD when tools developed in the USA were applied in 
European settings. Comprises paper-based risk charts for 
high-risk and low-risk European populations; national or 
regional risk charts based on published mortality data and a 
computer-based interface “Heartscore” for risk estimation 
data entry and calculation. The publicly available website 
includes a pro forma for calculating patients’ risk, 
management advice and allows clinicians to save patient data 
(once registered with the site). A downloadable version is 
available.  
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Risk stratification 
tool 
Studies Developer/origin Input data and implementation 
Scottish Patients at 
Risk of Readmission 
and Admission 
(SPARRA) 
National 
Health Service 
Scotland; 
Scottish 
Government 
Health 
Delivery 
Directorate: 
(2011). 
Public developer, 
commissioned by 
Scottish 
Government 
Information Services 
Division from Health 
Dialog, UK.  
SPARRA scores risk of admission in the prediction year and 
can be accessed securely online by authorised health care 
professionals in NHS Scotland Boards, Community Health 
Partnerships and GP practices. Three iterations of this tool 
have been developed. Version 1 stratified population >65 
years, version 2 extended this to whole-of-population and 
version 3 includes new prescription data input. The algorithm 
is based on hospital inpatient admissions; community 
dispensed prescriptions; emergency department (ED) 
attendances; new outpatient attendances; and psychiatric 
inpatient admissions. Colour coded data visualisation is 
available. 
A purposefully 
developed risk 
stratification tool for 
the Indiana Chronic 
Disease Management 
Program (ICDMP tool) 
Katz, Holmes, 
Stump et al. 
(2009); 
Rosenman, 
Holmes, 
Ackermann 
(2006) 
Commissioned by 
Indiana Medicaid 
from vendor 
Regenstrief Institute 
Used to assign participants to different program services 
(nurse care managers to highest risk 20%; telephone care 
coordinators to remaining 80%). Algorithm based on two 
years of retrospective claims data 1) total net Medicaid claims 
in past 12 months; 2) Medicaid aid category (eg. 'aged' or 
'disabled'); 3) total number of unique medications filled in 
past year. 
A purposefully 
developed risk 
stratification tool 
based on the 
American Diabetes 
Association Clinical 
Practice (ADACP tool)  
Clark, Snyder, 
Meek, et al. 
(2001) 
Commissioned by 
Las Vegas Managed 
Care Organisation 
from Roche 
Diagnostics 
Corporation. 
Uses laboratory tests and data from completed patient 
questionnaires to generate risk profiles (high-, moderate-, or 
low-risk) groups in seven categories: 1) glycaemic control, 2) 
cardiovascular disease, 3) nephropathy, 4) retinopathy, 5) 
hyper/hypoglycaemia, 6) amputation, and 7) psychosocial 
disorders. Data is entered and retrieved from a web-based 
interface. 
A purposefully 
developed built 
Medicaid data model 
for the 
“Hosptial2Home” 
scheme 
Lewis 2012 Adapted version of 
a reported 
algorithm 
developed at New 
York University, 
USA.  
Identifies disabled adult patients eligible for mandatory 
managed care enrolment in New York, USA. Data is drawn 
from Medicaid Fee-for-Service claims. Variables include prior 
utilisation history, including frequency of and intervals 
between hospital admissions and ED visits, primary care and 
specialty care visits, and use of a broad range of other 
services (such as home care, personal care, rehab services, 
substance abuse services, prescription drugs, and so on), 
prior diagnostic history age, gender, race/ethnicity and 
geographical location. The tool is used to determine cost 
profiles and business case modelling. 
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7  Question 2: 
Of these strategies or approaches, what key factors 
have been identified as critical enablers and/or 
barriers to successful implementation at a system 
level? 
Key findings 
 
Evidence of critical enablers and barriers to successful implementation was weak and relied on descriptive 
case studies and qualitative studies. We identify four key areas of implementation in which there are critical 
enablers and/or barriers.  
 
1) The Engagement of clinicians in tool implementation, refinement and end-use.  
 
 Clinicians who already had an understanding and sympathy for population health 
perspectives were the easiest to engage 
 
 Investment in education and training may increase clinician engagement 
 
 Clinicians are more likely to use a risk stratification tool if they are given some independence 
to access and use data from the tool 
 
 A system that blends the use of a risk stratification tool with clinical judgement may improve 
acceptance amongst clinicians  
 
 The introduction of a risk stratification tool can lead to quite different patterns of patient 
flow. Existing systems (and staff) can be overwhelmed without careful planning. 
 
2) The context in which the tool was introduced into the healthcare system 
 
 Introducing a risk stratification tool within a clearly articulated broader strategy with two-
way communication between planners and healthcare providers can facilitate success. 
Related initiatives should be developed in parallel. 
 
 Some examples of successful implementation could be characterised as ‘top-down’ with 
centralised data collection, distribution and funding. 
 
 The wider operating environment can act as a barrier or facilitator to success; factors include 
incentives in other parts of the healthcare system that might encourage/discourage the 
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adoption of new models of care.  
 
3) Data requirements and characteristics of the tool 
 
 Commissioners have the option to develop a new tool or purchase an existing tool and adapt 
it locally. There is no strong evidence to indicate which option is more cost effective  
  
 Reliable up-to-date data is required to populate risk stratification tools 
 
 Linked, or preferably centralised, data collection systems facilitate prompt accurate 
prediction 
 
 Tools that have been adapted to local contexts by using locally relevant indicators and 
validated locally may be more reliable. Tools developed in other countries may over- or 
under-predict risk when applied locally 
 
 Some tools that are intended to be populated with clinical data gathered directly from the 
patient can be adapted for use with administrative data. 
 
4) Equity issues 
 
 The collection and linkage of patient data requires strong data protection systems. Data 
protection laws and regulations increase the complexity of the environment in which risk 
stratification tools are implemented 
 
 More targeted ‘impactibility’ models (that identify patients that may benefit most from a 
particular intervention) are contentiously debated in the literature. Some jurisdictions have 
rejected this approach on equity grounds. 
 
Overview 
 
Evidence of critical enablers and barriers to successful implementation was weak and relied on descriptive 
case studies and qualitative studies. We identify five key areas of implementation in which there are critical 
enablers and/or barriers. 
 
The studies surveyed here were predominantly single case studies, with a few comparative cases. The 
studies with the strongest focus on implementation used qualitative methods and these were more likely to 
look specifically at the risk stratification instrument 
[9,10,11,13,15]
. Most of the qualitative research focused on 
how instruments were used (or not used) in practice, particularly the active involvement and support of 
clinical staff. The Indiana Chronic Disease Management Scheme study 
[8]
, was typical of most of the more 
quantitative studies, in this case based on Medicaid claims data. This cluster-randomised study provided the 
only longitudinal study, however, despite descriptions of the development of a new risk stratification 
instrument, the study focused on effects of the whole chronic care program. Several papers were reviews of 
a variety of studies 
[23, 24,25, 33
]. These have been drawn on partly because of the lack of stronger evidence in 
some areas. However, the quality of the evidence they assemble is weaker than other studies. 
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Key areas 
 
 Engagement of clinicians 
 
The Basque Country study 
[9]
, which looked at a population level adoption of the Johns Hopkins University 
Adjusted Clinical Groups, used qualitative methods to describe the engagement of clinicians. Those who 
already had an understanding and sympathy for population health perspectives were the easiest to engage. 
An investment in education was needed to bring others around.  
 
Clinicians were also more likely to use the tool if they were given some independence to access and use 
data from the tool. This was a persistent theme. In Clarke’s study, [7] stratification data was prepared in a 
form that patients could read, and was used as a method of improving health literacy. The JADE controlled 
trial in Hong Kong 
[1]
 used a web-based system with a series of risk engines to stratify patients into different 
risk groups. Doctors could access this patient information with a portal that linked risk profiles to decision 
support tools and care guidelines following the recommendations of the International Diabetes Federation. 
GPs in the Prism study 
[11]
 were encouraged to continually compare their own understandings and 
expectations of patients’ risk scores. A review of predictive risk models [25] in use in the UK warned that 
engagement of clinicians at the point of implementation was essential: “clinicians need to understand how 
the predictions made by the model can help them in managing their population with long term conditions”.  
 
A German study of risk stratification in primary care argued that acceptance among patients and primary 
care providers was higher if case finding involved some judgement by the clinicians. Risk stratification 
helped counter a personal sympathy/aversion element that biased doctor’s judgements about which 
patients to admit to a new program. However, risk stratification on its own lacked an important capacity to 
judge patients’ “willingness and ability to participate” and “manageable care needs” [10].  
 
This factor became a barrier to the take-up of PARR in Virtual Wards in Croydon Primary Care Trust in 
London 
[15]
. GPs resisted the selection of patients purely on the predictive risk model, and even asked to 
have a right to select who was admitted to treatment. The largest challenge to the use of PARR remained a 
perception that it led to referrals “from a computer”.  
 
The only study to attempt a rigorous implementation science framework 
[33]
 advocated a knowledge 
brokering team to develop relationships with users of its Diabetes Population Risk Tool (DPoRT). This 
Canadian tool draws on publicly available data to develop a population level risk tool and then uses tailored 
training and customised dissemination strategies to present the model to decision makers. At present, this 
project is still at the stage of a protocol for a full evaluation.  
Other workforce issues included concerns about overloading healthcare providers. The introduction of 
stratification 
[7]
 can lead to quite different patterns of patient flow. Existing systems (and staff) can be 
overwhelmed without careful planning. 
 
 Contexts of introduction 
 
One key to the successful introduction of new instruments in the Basque Country was its positioning within 
a clearly articulated broader strategy with two-way communication between planners and health care 
providers 
[7], 9]
. Provider buy-in was necessary from the start. While the technical task of linking primary care, 
hospital and other data made the implementation of risk stratification feasible it was noted that: “For 
population stratification to be most useful and practical, other initiatives should be developed in parallel, 
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such as better integration of health care and social care services, education and training, the creation of new 
job descriptions, or the re-organisation of clinicians’ working patterns and time spent on case management 
tasks”. [28] 
 
Some examples of successful implementation could be characterised as ‘top-down’. The Indiana Chronic 
Disease Management Program 
[17]
, based on Medicaid recipients, relied on the active support of the Indiana 
state government and access to its centralised Medicaid claims data. This program base enabled 
development and use of the risk stratification tool. Using a single, restricted program also sets some limits. 
State Medicaid agencies have limited management capacity to create and run disease management 
programs with a more population or system-level approach.  
 
Other centralised systems have transcended some of these difficulties with more integrated models, 
drawing across different sectors of care. Kaiser Permanente 
[6]
 has provided the most influential model of a 
closed system that draws on linked data from primary care and hospitalisation to develop sophisticated 
predictive risk models. The Scottish SPARRA risk tool 
[12]
 has also developed a more centralised and 
integrated approach. SPARRA uses one central data collection and processing unit. This population-level 
risk tool is run centrally with information sent out to primary care or through a secure and user-friendly, 
colour coded online portal. GPs can use the portal to access and use their own data.  
 
A comparison of three English case studies of ‘Virtual Wards’, a model of integrated primary and social care 
[13]
, saw the wider operating environment as the main condition enabling successful implementation of risk 
stratification tools. These elements included the organisational culture, the existence of multidisciplinary 
teams and active patient participation.  
 
The Croydon Virtual Wards model was launched in 2006 in a national health policy climate that encouraged 
this type of intervention and especially the use of predictive tools for case finding. It received strong support 
at managerial level, from the Primary Care Trust and local medical committee, including access to GP data 
managed by the Trust, which fed into the Combined Predictive Model. The weakness of the Croydon 
model lay in its detachment from the GPs. The model of case management was one-on-one by a matron, 
with no role for case management by a multidisciplinary team including GPs. Regular ‘mortality and 
morbidity’ meetings were held between the PCT and practice organisations, but GP involvement remained 
elusive. Community matrons and other community healthcare providers used a common electronic medical 
record, but these were not available to GPs or hospitals. As a result, the care plans based on risk modelling 
were based on informal collaboration between matrons and GPs, plans that were often not documented and 
did not draw directly on risk modelling. There was no portal with which GPs could access data from the risk 
predictive instrument. In these circumstances, as the program matured there was a steady retreat from 
multidisciplinary case management back to traditional care.  
 
In contrast, a model in Devon was more rooted in primary care, championed by a GP and only taken up by 
the Primary Care Trust after his/her advocacy. The Devon model, based on a local variation of the CPRM, 
received good take up in primary care. It also struck some real problems, but these were came from the 
bureaucratic structures of the local PCT organisation, including perverse financial incentives for hospitals to 
admit more patients, undermining one of the main objectives of the program. 
 
A third model, in Wandsworth, also had considerable initial support from general practice. Wandsworth 
used PARR as its risk stratification tool. This choice strengthened GP support, but at the expense of an 
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effective risk predictive system. In contrast to the whole population approach of the Combined Predictive 
Risk Model, used by Croydon and Devon, the Wandsworth PARR tool throws a smaller net, only looking for 
patients with a prior hospitalisation. With fewer at-risk patients identified, it relied on GPs for referrals – only 
a quarter came through the risk prediction tool.  As a result, it remained more popular with local GPs, who 
could refer their difficult-to-manage patients. 
 
 Data and the tool 
 
Studies of clinician take-up 
[16]
 emphasised the need for reliable, up-to-date data. The Basque Country study 
[7]
 
28]
 added that clinicians wanted to be able to access and use the data independently, with usable 
information, social as well as strictly medical data, at the group as well as the individual level. However, a 
New Zealand survey of risk instruments 
[27
] has warned that inclusion of non-needs based social indicators, 
such as gender, to predict risk may mean some groups are unfairly offered more interventions.  
 
A Valencia study 
[19]
, on the use of risk stratification tools within a chronic disease management program 
(the Sustainable Social and Healthcare Model) drew participants from three local health departments. This 
program was based primarily on hospital avoidance and made successful use of centralised administrative 
data to stratify patients, drawing directly from hospital and clinical information systems, rather than the 
usual telephone or interview methods used with CARS and Pra. 
 
A regular theme was the need for risk stratification tools and data to be usable in other contexts. The 
Framingham Risk Score 
[20]
 was used as a risk stratification tool, but also to educate patients about care 
options and for guidance on choosing the best care options. The study reported some success in patients 
deciding to address risk factors (although there was no follow-up on how long this resolution lasted). The 
FRS is based on historical population cohort, whose characteristics and needs differed from contemporary 
primary care populations. Attempts to modify its formula were found to be ‘sub-optimal’. 
 
The evaluation of the implementation of Prism 
[39]
 found complexity and difficulties in signing up and 
unforeseen incompatibilities in computer systems were major barriers to early take-up. The PARR model 
[15]
, 
which is based on recent hospitalisations, was easier to use, but had limited usefulness for the general 
population. The more sophisticated Combined Predictive Risk Model, which can deal with broader 
populations, needed to be adapted to local circumstances, which made it more costly and time intensive to 
implement. 
 
Knutson’s ‘Predictive Modelling Guide’, an operating manual produced for the Medicaid program [23] argued 
that users (in this case US states) would achieve considerable savings by developing their own predictive 
models rather than licensing commercial products. A case study of Washington State suggested that this 
enhanced the ability to customise the instrument, drew – and built upon – knowledge of local population 
data, and strengthened connections between data managers and care staff. Start-up costs were estimated 
as higher, but local ability to modify the instrument saved up to an estimated 25% of costs in the longer 
term. This favourable outcome was dependent on the ability to find and keep staff, including software 
engineers, health economists and statisticians. Washington State was also helped by 10 years’ experience in 
building a data integration system. 
 
A review of risk predictive models in the United Kingdom 
[25]
 sets out the business case for implementing a 
predictive model. This would include setting a risk score threshold and the desired reduction in hospital 
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admissions and the cost of the intervention. The key cost factors rest on the availability of data and the 
expense of obtaining new, necessary data. Privacy and security concerns must be costed, as data must be 
available in pseudonymous form – raw data or identified data should only be available to clinicians who 
know the patient. The cost of the algorithm tool itself includes the software on which it is run and the labour 
and dissemination expenses. 
 
The comparative study of ‘Virtual Wards’ [13] found that the Devon version of the CPRM, which had started 
with solid foundations in primary care, faced its worst difficulties with issues of data management, especially 
information governance. Major problems arose in extraction of data from GP systems for predictive 
modelling and with the system for transferring information back to GPs to give their patients’ predictive risk 
scores. Most obstacles came from data protection and other legislative and administrative safeguards, 
rather than GP resistance.  
 
The NHS England: Case Finding & Risk Stratification Handbook 
[24]
 points to a legal labyrinth of data 
protection and human rights legislation and the Common Law Duty of Confidentiality. Patient consent and 
data pseudonymisation (using the encryption of NHS identification numbers) are seen as the two routes 
through these legal barriers. 
 
 Equity issues 
 
Most issues of equity came from the design of the instrument and other data issues. For example, the 
Nuffield Trust survey of the use of risk stratification instruments in the English NHS raised privacy issues 
around data linkage 
[30]
. 
 
More targeted ‘impactibility’ models were discussed because of evidence that they are superior for 
identifying patients with complex but manageable comorbidities 
[40]
. These models take the results of a 
more standard predictive model and try to predict the sub-groups of these at-risk patients who are most 
likely to respond to case management. The Croydon ‘Virtual Wards’ study [15] rejected this approach on 
equity grounds, as the measure of likely success is likely to exclude patients with substance abuse, mental 
illness or other disadvantages. 
 
Assessment 
 
 Successes and failures 
 
The measurement of ‘success’ is a complex question. The answers to question 1 showed the weakness of the 
evidence in current research in this area. Risk stratification is only a preliminary step to clinical and other 
interventions. Those (few) studies which attempted to measure system level outcomes 
[1]
 made no attempt 
to separate the effects of risk prediction and the actual intervention.  
 
An exception to this lack of attention on clinical outcomes was studies that looked at the secondary use of 
data drawn from risk stratification, especially effects on changing systems of practice. Where clinicians had 
easy, user-friendly access to data concerning their own patients, there was greater acceptance of risk 
stratification. This was especially true where the stratified data was linked to clinical guidelines to suggest 
directions for treatment. The other side of the coin was reports of the use of risk stratification results in 
patient education.  
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A second dimension of success was the implementation of the tool itself, regardless of the clinical impact of 
the broader intervention. Here again, there was a broad distinction between studies of settings and 
interventions that included the delivery of primary care and those starting from hospital settings, the closed 
environment of the Kaiser Permanente system or centralised claims data. The latter showed little or no 
concern with the active support of clinicians 
[8, 17,19,30]
. Every study involving primary care, especially general 
practice, saw the engagement of clinicians as the key to success. These ranged from studies of risk 
stratification within primary care 
[10, 15]
, through to the more integrated Scottish and Basque health systems 
[9,12]
,). These distinctions between drivers of successful implementation crossed system boundaries and were 
the one generic predictor of successful adoption. 
 
In primary care, active engagement of GPs emerges as a common thread in successful implementation. GPs 
have been involved in design from the start. More importantly, they have found direct benefits for their 
patients in access to the results of risk stratification tools PR. This has often taken the form of web-based, 
user-friendly portals, often linked to evidence-based trusted decision tools offering appropriate guidance 
for the particular risks faced by a patient. Risk stratification tools are a supplement not a replace of clinical 
judgement 
[24]
. 
 
As seen with question 1, some of the trials currently underway may provide better answers to the broader 
effects of risk stratification, improving implementation. The Prism trial 
[32]
 is looking at the costs of 
implementation and the cost effectiveness of the instrument (using cost per quality-adjusted life year based 
on changes in patient health outcomes) – questions that no other study in this review has broached. It will 
measure changes in the profile of the services provided to patients and levels of patient satisfaction. It will 
also look at broader contexts than those in previous studies: how the Prism instrument is understood, 
communicated and used by the clinicians, managers, local commissioners and policy makers. 
The DPoRT 
[33]
 knowledge translation protocol promises “approaches specifically designed to support the 
application of tools designed to generate future population-level risk profiles to facilitate decision making”.
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8  Question 3: 
How were these models adjusted or adapted 
during or after the evaluation to take account of 
critical enablers and barriers? 
Key findings 
 
Changes during implementation or after an evaluation of the use of a risk stratification tool were rarely 
discussed in the identified studies. Evidence is from descriptive case studies only and therefore weak.  
 
 In some jurisdictions the predictive accuracy of an ‘off-the-shelf’ risk stratification tool was 
found wanting when applied in local contexts. Tools were adapted using new locally relevant 
indicators and validated locally  
 
 Most tools are re-calibrated on a regular basis (every 2−4 years) 
 
 In some jurisdictions, the introduction of training and information packages for clinicians 
increased engagement, with and acceptance of, a risk stratification tool 
 
 In some jurisdictions, the implementation of the tool was changed to formally include clinical 
judgement in the decision making process, either at the point of decision to treat, or by 
establishing new criteria for inclusion/exclusion through surveying clinicians’ opinions 
 
 The mechanism through which tool outputs are distributed to clinicians has evolved over 
time. In early approaches data was sent to clinicians via email or mail, resulting in a time-lag 
and the impression of out-of-date data. More recently clinicians can access tool outputs 
through secure web-based user interfaces 
 
 The frequency at which the risk stratification algorithms tend to be run has evolved from 
periodic (six-monthly, monthly) to continual.  
 
Adaptations and adjustments 
 
An early study of the Welsh Prism Chronic Care Demonstration project 
[11]
 reported that first responses to 
the tool were “mixed”but found that user involvement (again from GPs) in developing improved versions of 
the tool helped reverse initial failures. Resistance from GPs to the risk modelling associated with the 
Croydon ‘Virtual Ward’ was seen as at least partly due to the novelty of the predictive risk model as a 
concept 
[15]. The King’s Fund led a series of presentations to GPs, setting out the evidence base for predictive 
modelling and explaining its advantages in accuracy over clinical opinion. This does not seem to have been 
very persuasive as it then took “months” for all relevant parties to reach agreement. 
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Other studies continued the theme of clinician engagement. The Israeli ACG model 
[18]
 has had problems 
with an instrument that included excessive proportions of very high-risk patients. This is being resolved with 
a panel of six doctors who make exclusions on clinical grounds from those identified by the instrument. The 
German primary care-based study 
[10]
 argued that problems of excessively rigid risk predictive algorithms 
could be resolved by bringing the implementation of the tool closer to needs and values of final users. It 
reiterated the message common to all the primary care based studies: that clinicians need to be involved in 
development of risk stratification tools from the start. 
 
There were several reports of managing change while improving tools or adapting tools used in other 
jurisdictions. For example, in the Nairn district in Scotland the Nairn Case finder 
[2] 
was implemented with 
particular features to improve on aspects of the related SPARRA tool. SPARRA, sent updates six-monthly 
and was therefore considered to be based on potentially old data; it was (at the time) based on hospital 
data as inputs. The Nairn Case Finder was run on a monthly basis centrally in the practice to enable 
communication with the anticipatory care team and was changed to include GP data.  
 
Surveys of instruments, such as Knutson’s ‘Predictive Modelling Guide’ for Medicaid [23] argue for continuous 
improvement of data. The risk score should always be seen as a starting point and must be supplemented 
by a continuous process of using non-traditional data – functional status, social context and health 
behaviours and attitudes. This involves “continuous and targeted data mining”. The Indiana Chronic Disease 
Program 
[17]
 gradually broadened the basis of its scoring of risk. It started with a cost-effectiveness model, 
using Medicaid claims data to target high intensity intervention to those participants most in need. The 
study reported that enhanced stratification algorithms were being considered to broaden the types of 
information used in calculating risk. This would include more self-reported data collected by telephone from 
program participants, including self-rated health, expected health service utilisation in the next year and 
whether a participant names an individual doctor as their primary source of care.  
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9  Question 4: 
What key learnings are to be derived from 
implementing strategies or approaches to risk 
stratification, from a system wide perspective? 
Despite the lack of strong studies – and the complete dearth of Australian evaluations of risk predictive 
instruments − some learning points can be extracted that are relevant to the NSW context. 
 
 A state-wide approach to risk stratification will need to decide on whether to purchase a ready-
made commercial risk stratification tool, or develop a new one. The literature demonstrates some of 
the benefits of starting afresh, especially in developing around local data sources and problems. 
The pitfalls are also clear, mainly around workforce and cost 
 
 The design of a new tool or adaptation of a ready-made one will depend on ready availability of 
relevant linked data, minimal expenditures and labour to link incompatible systems 
 
 The risk stratification tools that met greatest acceptance and fewer teething problems were 
embedded in clearly explained, broader disease management and care integration strategies 
 
 The risk stratification tools that won swiftest support from clinicians were designed with user-
friendly portals so that doctors, other health practitioners and wherever possible, patients, could 
access useful information, often linked to decision-aids relevant to the patient’s risk group 
 
 Data protection and privacy issues need to be sorted out very early 
 
 Health care practitioners, especially in primary care, were more likely to embrace new methods of 
case finding if they were consulted at every stage. If they could see a clear benefit to their own 
patients, they were much more prepared to make some of the changes in practice required and less 
likely to see risk stratification tools as an attack on clinical judgement 
 
 Considering the lack of publicly available information on the implementation of risk stratification 
tools in real-world settings, any adoption of such an approach in NSW should include rigorous 
evaluation.  
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11  Appendices 
Appendix 1: Search terms adapted to included databases 
 
Medline via OvidSP 
 
Risk stratificat*.tw OR Risk profil*.tw OR Population profil*.tw OR Population segment*.tw OR Predictive 
risk.tw OR (Predict* adj3 model).tw OR Risk adj4 Predict*.tw OR (Risk adj3 Population*).tw OR (Risk adj3 
model*).tw OR Stratificat* adj3 strateg*(.tw) AND Health services [MeSH] OR Managed Care Programs 
[MeSH] OR Primary Care (or Primary Health Care [MeSH]) OR Aged Care.mp OR Hospital [MeSH] OR Health 
System.mp OR Population health.mp AND Models.tw OR Tools.tw OR Program.tw OR System.tw 
Filter by year: 2000−2015 
 
Embase 
 
(('health services' AND [2000−2015]/py) OR (managed AND care AND [2000−2015]/py) OR ('primary care' 
AND [2000−2015]/py) OR (aged AND care AND [2000−2015]/py) OR ('hospital' AND [2000−2015]/py) OR 
('health system' AND [2000−2015]/py) OR ('population health' AND [2000−2015]/py)) AND (('models' AND 
[2000−2015]/py) OR (tools AND [2000−2015]/py) OR ('program' AND [2000−2015]/py) OR ('system' AND 
[2000−2015]/py)) AND 'population risk'/exp 
 
CINAHL 
 
"Risk stratificat*" OR (MM "Risk Assessment") "Risk profil*." "Population profil*." ""Population profil*."" OR 
"Stratificat* strateg*" AND (MM "Health Services for the Aged") OR (MH "Health Services+") OR "Health 
services" OR (MH "Managed Care Programs+") OR "Managed Care" OR (MH "Multidisciplinary Care 
Team+") OR (MH "Health Care Delivery, Integrated") OR "Primary Care" OR (MH "Primary Health 
Care") "Hospital" OR (MH "Health Facilities+") AND "model*" "tool*" "program*" OR"System"  
Filter by year: 2000−2015 
 
Scopus 
 
( TITLE-ABS-KEY ( "risk stratific*" ) OR TITLE-ABS-KEY ( "risk predict*" ) OR TITLE-ABS-KEY ( "populat* risk" ) 
AND TITLE-ABS-KEY ( "health servic*" ) OR TITLE-ABS-KEY ( "health system*" ) OR TITLE-ABS-
KEY ( hospitalis* ) AND TITLE-ABS-KEY ( model* ) OR TITLE-ABS-KEY ( system* ) OR TITLE-ABS-KEY ( tool* ) 
OR TITLE-ABS-KEY ( program* ) AND TITLE-ABS-KEY ( populat* ) ) AND SUBJAREA ( mult OR medi OR nurs 
OR vete OR dent OR heal ) AND PUBYEAR > 1999 AND PUBYEAR < 2016 AND ( LIMIT-TO ( LANGUAGE , 
"English" ) ) AND ( LIMIT-TO ( SUBJAREA , "MEDI" ) OR LIMIT-TO ( SUBJAREA , "SOCI" ) OR LIMIT-
TO ( SUBJAREA , "NURS" ) OR LIMIT-TO ( SUBJAREA , "HEAL" ) OR LIMIT-TO ( SUBJAREA , "ECON" ) OR 
LIMIT-TO ( SUBJAREA , "ARTS" ) OR LIMIT-TO ( SUBJAREA , "BUSI" ) )  
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Cochrane library 
 
"risk stratification" in Title, Abstract, Keywords or "risk stratification model" in Title, Abstract, Keywords and 
"health care" in Title, Abstract, Keywords or "health care facilities" in Title, Abstract, Keywords or "health care 
delivery" in Title, Abstract, Keywords in Other Reviews
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Appendix 2: PRISMA flowchart 
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Appendix 3: Table of included papers  
# Author (year) Setting Risk stratification 
tool(s) applied 
Evidence type – design (NHMRC 
level of evidence) 
Key results / factors influencing implementation 
1 Arce, De Ormijana,  
Orueta, et al. 
(2014) 
PC practices, 
Basque Health 
Service, Spain 
Johns Hopkins 
University Adjusted 
Clinical Groups 
Qualitative study − purposive sample of 
12 GPs and 11 PC nurses in PC centres 
that adopted tool participated in focus 
groups. (n/a) 
Factors influencing implementation: Clinicians’ views on the tool and on the 
implementation process are closely interlinked and influence each other. 
Enablers and barriers identified related to: characteristics of adopters; clinicians 
values; degree to which risk stratification is part of a broader strategy with 
good communication; independence of end users to manage information; up-
to-date data; communication strategy; practice settings; workload; reliability of 
the tool; ease of use; equity risks of targeting; resistance to change to a 
population approach. 
2 Badenbroek, 
Stol, Nielen et al 
(2014) 
PC practices, 
The 
Netherlands 
Finnish Diabetes Risk 
Score (FINDRISC) 
Protocol, evaluation with randomised 
stepped-wedge waiting list control 
group – patients in a representative 
sample of 40 PC practices risk stratified 
and offered a care management 
package. (II) 
  
Results expected 2016. 
3 Baker, Leak,  
Ritchie, et al. 
(2012) 
PC practices, 
Nairn, 
Scotland, UK 
Nairn Case Finder Evaluation with concurrent cohort 
control – 96 patients each from two 
similar PC practices were matched for 
age, sex, multiple morbidity indexes, and 
secondary care outpatient and inpatient 
activity. Patients from one practice 
received a managed care plan, the other 
acted as control. (III-2) 
Mortality rates in the two cohorts were similar, but the hospital bed days used 
in the last three months of life were significantly lower for the decedents with 
an Anticipatory Care Plan. 
Factors influencing implementation: use if primary care vs. hospital data for 
populating tool, time delay between data provision and front line use of tool. 
4 Boult, Boult, 
Morishita et al. 
(2001) 
PC practices, 
Ramsey 
County, 
Minnesota, 
USA 
Pra instrument Evaluation with randomised control −
Medicare beneficiaries age 70 and older 
were stratified using Pra. Baseline 
measurements were obtained for all high 
risk respondents (Pra >0.4) (N=570). 
Patients were matched according to Pra 
stratification block and randomised. 
Control patients received care their 
physician deemed appropriate after 
receiving notification of risk. Intervention 
group patients received an 
interdisciplinary care package. (II) 
Intention-to-treat analysis showed that participants receiving the care package 
were significantly less likely than the controls to lose functional ability (adjusted 
odds ratio (aOR) 0.67, 95% confidence interval (CI) 0.47–0.99), to experience 
increased health-related restrictions in their daily activities (aOR 0.60, 95% CI 
0.37–0.96), to have possible depression (aOR 0.44, 95% CI 0.20–0.94), or to use 
home healthcare services (aOR 0.60, 95% CI 0.37–0.92) during the 12 to 18 
months after randomisation. Mortality, use of most health services, and total 
Medicare payments did not differ significantly between the two groups. 
Factors influencing implementation: Instrument can be used off the shelf; 
paper-based, self-administered tool.  
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# Author (year) Setting Risk stratification 
tool(s) applied 
Evidence type – design (NHMRC 
level of evidence) 
Key results / factors influencing implementation 
5 Boult, Leff, 
Boyd et al. (2013) 
Eight 
community-
based PC 
practices in 
Baltimore, MD 
and 
Washington 
DC, USA 
Hierarchical 
Condition Category 
(HCC) 
Evaluation with randomised cluster 
control. Patients were selected for initial 
screening according to age (>65) and 
type of insurance coverage. Patients 
were potentially eligible if their HCC risk 
ratios were in the highest quartile of the 
population of same age category 
patients covered by their health care 
insurer. Patients were randomised by 
cluster (i.e., by team of physicians). 419 
patients received usual care and 485 
received the ‘Guided Care’ package 
comprising eight nurse led services. (II) 
In intention-to-treat analyses, Guided Care did not significantly improve 
participants’ functional health, but it was associated with significantly higher 
participant ratings of the quality of care (difference= 0.27), (95% CI=0.08–0.45) 
and 29% lower use of home care (95 % CI=3–48%). 
Factors influencing implementation: systematic identification and intensive care 
management (including frequent face-to-face contact) of high-risk patients; 
primary care physicians collaborating with on-site registered nurses and other 
staff (all working in redefined roles “at the tops of their licences”); health 
information technology that facilitates coordinated care. 
6 Clark, Snyder, 
Meek, et al. (2001) 
Managed Care 
Organisation, 
Las Vegas, 
USA 
Purposefully 
developed tool 
based on the 
American Diabetes 
Association Clinical 
Practice  
Evaluation with a concurrent cohort 
control. Two PC clinics each enrolled 370 
patients (N=740) who received the 
intervention. Data from 623 members at 
a third clinic acted as control. Patients 
were stratified into high-, moderate-, or 
low-risk groups within disease 
categories. Interventions were based on 
previously agreed-upon care plans after 
approval from the primary care 
physician. Complete data were available 
from 193 patients who completed the 
program to 12 months. (III-2) 
The number of patients in the low-risk category (HbA1c ,7%) increased by 
51.1%. A total of 97.4% of patients with an HbA1c >8% at baseline had a 
change in treatment regimen. Patients at the highest risk for coronary heart 
disease (LDL 130 mg/dL) decreased from 25.4% at baseline to 20.2%. Patients 
with a blood pressure, 130/85 mmHg increased from 23.8% to 44.6%. Patients 
and providers expressed increases in satisfaction with the program. 
Factors influencing implementation: Patients educated and informed of their 
data and risk status (to prepare for PC visit); close involvement of PC providers 
to assure standards and recommended actions were consistent with 
practitioners’ views; altered patient flow; a system that collated the data and 
presented it in a format that was immediately understandable by (and useful 
to) the patient and the provider; automated clinical decision support and 
reminder lists for a team care coordinator. 
7 Cohen, Flaks-
Manov, Low et al. 
(2015) 
Clalit Health 
Services, Israel 
Johns Hopkins 
University Adjusted 
Clinical Groups 
Descriptive case study – the Clalit Health 
Service implemented a system whereby 
the selection of patients for inclusion in 
a managed care program combined risk 
stratification through the tool with a set 
of additional exclusion criteria created 
through a survey of physicians eliciting 
the clinical basis on which they currently 
identify high-risk patients. (n/a) 
Factors influencing implementation: A combined predictive risk tool-clinical 
input approach to patient selection for care management; accounting for 
impactibility, predictive accuracy, and resource capacity. 
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# Author (year) Setting Risk stratification 
tool(s) applied 
Evidence type – design (NHMRC 
level of evidence) 
Key results / factors influencing implementation 
8 de Manuel, 
Keenoy, Mora et 
al. (2014) 
PC services for 
aged in 
Europe 
Various Protocol, comparative case studies. Work 
packages include: development of a 
standard for appraising stratification 
tools; analysis of the feasibility of using 
tools in healthcare including barriers and 
facilitators; impact of stratification tools 
on structure and processes of healthcare 
organisations, on health services 
resources, management and clinical 
practice. (n/a)  
Expected in 2015. 
9 Dhalla, O'Brien, 
Morra et al. (2014) 
Toronto 
Central Local 
Health 
Integration 
(Hospital) 
Network, 
Toronto, 
Canada 
LACE  Evaluation with randomised control −
high risk patients identified using the 
LACE tool administered at discharge in 
four hospitals were randomly allocated 
to either admission to a ‘Virtual Ward’ 
(N=963) or usual care (N=960). (II) 
 
There were no statistically significant differences between groups in hospital 
readmission or death at 30 or 90 days, six months, or one year. There were no 
statistically significant interactions to indicate that the Virtual Ward model of 
care was more or less effective. 
Factors influencing implementation: Hospital led and implemented tools with 
no integration with primary care services. 
10 Dixon, Lewis,  
Rosen et al (2004) 
Managed Care 
Organisations 
in the USA 
Various Review of tools – the approaches of five 
MCOs to the care of chronic disease are 
analysed in terms of 1) the wider 
environment in which they operated – 
for example, the use of market incentive; 
2) their organisational domain – 
including the relationship between 
healthcare purchasers and providers; 3) 
clinical process – such as the disease 
management programmes in place. (n/a) 
Factors influencing implementation: required investment in computer software; 
market pressures to reduce hospital costs for high risk patients; strength of the 
business model to identify incentives to implement tool; quality of data for 
linkage. 
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# Author (year) Setting Risk stratification 
tool(s) applied 
Evidence type – design (NHMRC 
level of evidence) 
Key results / factors influencing implementation 
11 Doñate-Martínez, 
Garces Ferrer,  
Rodenas Rigla, et 
al. (2014) 
Valencian 
Healthcare 
System, Spain 
Pra and Community 
Assessment Risk 
Screen (CARS) 
Descriptive case study – Pra and CARS 
were used to detect patients at risk of 
hospital readmission in a sample of 500 
patients aged >65. Administrative data 
were to populate the tools which, when 
purchased off-the-shelf need to be 
populated manually with a patient 
survey. Both tools implemented this way 
were found to have an acceptable level 
of accuracy in the prediction of hospital 
admissions. (n/a) 
 
Pra and CARS could be adapted for automatised risk stratification using a 
primary health administrative dataset. 
Factors influencing implementation: Availability of high quality linked data sets 
in primary care, hospital care and pharmaceutical prescriptions; ease of use for 
patients and practitioners. 
12 Freund, Wensing, 
Geissler et al. 
(2012) 
PC Practices, 
Munich, 
Germany 
Case Smart Suite 
Germany (CSSG) 
Qualitative study – 12 PC physicians first 
selected 30 patients for inclusion in a 
managed care program using clinical 
judgement and then again using the 
CSSG tool. Semi-structured interviews 
were used to elicit how the PC physicians 
experienced using CSSG. 
Overall, PCPs rated the approach useful for identifying patients likely to benefit 
from care management. However, they were concerned about time lags 
between data analysis and patient recruitment/adherence.  
Factors influencing implementation: Acceptance may increase among both 
patients and PCPs if case finding involves judgement by PCPs. 
13 Georghiou, Blunt,  
Stevenson et al. 
(2011) 
UK and USA Various Review of tools – reviews uses, 
limitations, and emerging developments 
of risk stratification tools. (n/a) 
Factors influencing implementation: Privacy protection; quality of 
administrative datasets; linkages to resource allocation. 
14 Hutchings, Evans, 
Fitzsimmons et al. 
(2013) 
Wales, UK Prism Protocol, evaluation with cluster 
randomised stepped wedge design 
using mixed-methods. Primary care 
practices will be randomly selected to 
receive Prism and different time points 
thereafter use Prism with clinical and 
technical support. Costs, processes of 
care, satisfaction and outcomes at 
baseline, six and 18 months, using 
routine data and postal questionnaires 
will be assessed. Focus groups and 
interviews will be undertaken to 
understand how Prism is perceived and 
adopted by practitioners and policy 
makers. (II) 
Results expected in 2015. 
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# Author (year) Setting Risk stratification 
tool(s) applied 
Evidence type – design (NHMRC 
level of evidence) 
Key results / factors influencing implementation 
15 Jiao, Fung, Wong 
et al. (2014) 
GP practices, 
Hong Kong 
Joint Asia Diabetes 
Evaluation Risk 
Engine (JADE) 
Evaluation with matched control design 
– 1248 patients with diabetes were 
randomly selected for participation. 
Participants were matched by age, sex, 
and HbA1c level at baseline with a further 
1248 patients as the control group. 
Intervention were risk stratified as ‘very 
high’, ‘high’, ‘medium’ and ‘low’ risk. 
Different care management strategies) 
were applied according to each patient’s 
profile. (III-1) 
The intervention group had lower cardiovascular events incidence (1.21% vs. 
2.89%, P=0.003), and net decrease in HbA1c (−0.20%, P<0.01), SBP (−3.62 
mmHg, P<0.01) and 10-year cardiovascular disease (CVD) risks (total CVD risk, 
−2.06%, P< 0.01; coronary heart disease (CHD) risk, −1.43%, P<0.01; stroke risk, 
−0.71%, P<0.01). After adjusting for confounding variables, the significance 
remained for HbA1c, predicted CHD and stroke risks. 
Factors influencing implementation: Risk stratification directly linked to 
recommendations for care; user interface to allow direct access to practitioners 
and which includes decision support. 
16  Jones, Shah, Bruce 
et al. (2011) 
Community 
based PC 
practices, 
Pennsylvania, 
USA 
Framingham Risk 
Score 
Descriptive case study − patient-
reported data were obtained via a 
touchscreen device-administered 
questionnaire in PC practices practice 
and automatically combined with an 
electronic health record (EHR) data to 
calculate risk. Higher-risk patients 
viewed an interactive web-based tool 
and chose treatment options to modify 
risk factors. A real-time simulation 
indicated directly to patients their 
expected outcomes when the treatment 
option is followed. (n/a) 
Following a trial period during which 1068 patients used the device, the system 
was considered feasible for full implementation. The Framingham Risk Score 
was modified for final use. 
Factors influencing implementation: Stratification of risk within the primary 
care setting; limited availability of risk stratification tools in a format that is 
amenable for direct use by GPs together with patients in shared decision 
making; ability to link off-the-shelf tools with GP records. 
17 Katz, Holmes, 
Stump et al. (2009) 
Indiana 
Chronic 
Disease 
Management 
Program, USA 
Purposefully 
developed tool. 
Evaluation – multiple baseline study. The 
tool was used to stratify participants to 
highest 20%/lowest 80% risk and assign 
a care package accordingly. Program 
was rolled out in three regions of the 
state (Central Indiana in July 2003, 
Northern in July 2004 and South 
October 2004). During which 14 
repeated cohorts of Medicaid members 
were drawn over a period of 3.5 years 
and the trends in claims were evaluated 
using a repeated measures model. (III-2) 
There was a flattening of cost trends between the pre- and post-intervention 
initiation periods and these remained flat in the final year of follow-up. 
Factors influencing implementation: Targeting specific diseases; centralised 
uniform dataset capturing whole population; provision of decision-support 
with tool; use of risk stratification tool to determine composition of care 
package. 
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# Author (year) Setting Risk stratification 
tool(s) applied 
Evidence type – design (NHMRC 
level of evidence) 
Key results / factors influencing implementation 
18 Kingston (2010) NHS Wales Prism Qualitative study – focus groups and 
interviews with staff in 13 GP practices 
taking part in the demonstrator testing 
of Prism including locality planning 
coordinators and GP leads. (n/a) 
Clinicians found that most of the highest-risk patients identified through the 
tool were known to them as high-risk patients. However, there were examples 
of patients whose risk score was much higher or lower than they expected. For 
those higher risk patients, the data provided impetus to further investigate 
these patients. 
Factors influencing implementation: remote access to anonymised or raw data; 
privacy and data governance; separation of service planners to patients; 
complexity/simplicity of the sign up process to gain access to the tool; 
provision for end user feedback to improve tool; end user friendly interface; 
integration of social care data when tool is to be used for care integration. 
19 Knutson, Bella,  
Llanos. (2009) 
USA 
(Medicaid) 
Various Implementation Guide – guides key 
factors for consideration when 
purchasing and implementing off-the-
shelf risk stratification tools. (n/a) 
Factors influencing implementation: Design and reporting logic; correct 
calibration in context; frequency of calibration; data requirements and 
monitoring; time-lag specifications; costs. 
20 Lewis (2010) Croydon 
Primary Care 
Trust, UK 
Combined Predictive 
Risk Model 
Descriptive case study – whole of 
population under the jurisdiction of the 
PCT were risk stratified. “Virtual Wards” 
were established along geographical 
lines of density of high-risk individuals. 
Patients registered with one of the 
participating general practices were 
identified using the tool as high risk and 
admitted to a 'Virtual Ward' receiving 
managed care. The 'Virtual Ward' team 
received an alert if the patients dropped 
off the high-risk list and may be 
discharged. (n/a)  
Factors influencing implementation: Data requirements, data security and 
pseudonymous data; provision of a user-interface as part of an off-the-shelf 
tool; initial costs of establishing tool; frequency of recalibration; governance 
and responsibility for commissioning tools; setting a business case for 
adoption of tool; engagement of local clinicians at the point of 
implementation; linking use of tool to a wider population management 
strategy. 
21 Lewis, Curry, 
Bardley, (2011) 
United 
Kingdom 
Various Implementation guide – analyses a range 
of factors to consider at the 
commissioning stage if tool 
implementation. (n/a) 
Factors influencing implementation: opening of market to competition 
(decommissioning of public models); availability of high quality data; location 
where tool will be run (in PC practice, level of primary care organisation; 
regional health authority); tools set up costs. 
22 Lewis, 
Vaithianathan, 
Wright (2013) 
Croydon, 
Devon and 
Wandsworth 
PCTs in 
England, UK 
Combined Predictive 
Risk Model, PARR, 
Devon Predictive 
Model 
Comparative case studies (descriptive) – 
compares three uses of risk stratification 
tools in PCTs, the Combined Predictive 
Risk Model in Croydon; an adapted 
version with a new interface in Devon 
and the PARR model in Wandsworth. 
The study traced enablers and barriers to 
successful implementation. (n/a) 
The type of tool used was slightly different in each case presented. The nature 
of the Virtual Ward program differed in terms of composition of the 
multidisciplinary team, leading ‘Virtual Ward’ staff (community matrons, ward 
clerks, ward GP) and timing of implementation.  
Factors influencing implementation: Funder of the model and relationship to 
commissioning agency; operating environment; organisational culture; culture 
of integration/GP involvement; data sharing; program champions. 
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23 Lewis,  
Wright,  
Vaithianathan 
(2012) 
Croydon, 
Devon, 
Wandsworth 
and Somerset 
PCTs, Toronto, 
Canada and 
New York, USE 
PARR, Combined 
Predictive Model, 
Devon Predictive 
Model, LACE, 
purposefully 
developed tool 
based on Medicaid 
data 
Comparative case studies (descriptive) –
descriptive accounts of how six managed 
care schemes vary in terms of the use (or 
non-use) or risk stratification and 
composition of care packages. (n/a) 
Factors influencing implementation: Mobility of population/ability to reach 
patients; use of case managers from appropriate sector; using impactibility 
models to identify high priority patients. 
24 National Health 
Service England 
(2015) 
England, UK Various Implementation guide – summarised 
current requirements for data 
governance, privacy, and choosing a risk 
stratification tool in the free market. 
(n/a) 
Factors influencing implementation: Fair processes of data; information 
governance (changing regulations and requirements; pseudonymisation); 
stratifying whole vs. part population; end user friendly interface; supplementing 
risk stratification with self-assessment tools. 
25 National Health 
Service Scotland 
(2011) 
Scotland, UK SPARRA Qualitative study – 25 end users of 
SPARRA at Community Health 
Partnerships (CHPs), Health Boards, and 
PCPs completed a survey asking 1) to 
whom SPARRA data is forwarded; 2) 
local modifications to the output; 3) local 
additions to the output; 4) which data 
sharing protocols in place; 5) what are 
the local uses of SPARRA data and 6) 
suggested additional data/information 
to be included in the SPARRA output. 
(n/a) 
Patterns of dissemination were variable and complex; a small risk of duplication 
was identified as well as a risk that data does not always reach intended end 
users.  A range of approaches to data security were taken by SPARRA end 
users. Prescribing data was identified as highly desirable to augment the 
SPARRA algorithm.   
Factors influencing implementation: data security, time-lag between data entry, 
running tool and reaching end users; institutionalised feedback from end users 
to inform improvements in tool. 
26 Nuno-Solinis 
(2013) 
Spain Various Review of tools − outlines basic concepts 
of predictive modelling, describe some 
of the models that have been developed 
internationally with descriptive case 
studies from the Spanish National Health 
Service. 
Factors influencing implementation: Ability to link primary care and hospital 
datasets; inclusion of professionals and patients in implementation design; 
implementing risk stratification as part of a wider integrated health strategy; 
training in use of tool, patient identification by name and surname; end user 
friendly interface; usable information provided at both the individual and 
group level. 
27 Panattoni, 
Vaithianathan, 
Ashton et al. 
(2011) 
New Zealand 
and Australia 
Various Review of tools − reviews the current 
knowledge about PRMs and explores 
some of the issues surrounding the 
potential introduction of risk 
stratification tools to a public health 
system with the examples of New 
Zealand and Australia. (n/a)  
Factors influencing implementation: Confidence in accuracy of algorithm; data 
protection (e.g. pseudonymous keys); using non-needs-based indicators (e.g. 
gender) to predict risk might mean certain groups are unfairly offered more 
interventions. 
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28 Purdy (2010) United 
Kingdom 
Various Review of tools – reviews current 
knowledge on at risk populations, viable 
risk stratification tools, and feasible 
linked interventions. (n/a) 
Factors influencing implementation: Availability of data on individual patients; 
interaction of linked interventions with the particular social context; ability to 
use both PC and hospital data.  
29 Rosella, Peirson, 
Bornbaum et al. 
(2014) 
Ontario and 
Manitoba, 
Canada 
Diabetes Population 
Risk Tool (DPoRT) 
Protocol, qualitative evaluation – 
interviews, observer notes and surveys 
will be used to identity factors that 
facilitate uptake and overcome barriers 
to the use of the tool as intended 
though the application of a Knowledge-
to-Action framework. (n/a) 
Results expected in 2015. 
30 Rosenman, 
Holmes, 
Ackermann (2006) 
Indiana 
Chronic 
Disease 
Management 
Program 
Purposefully 
developed tool 
Descriptive case study − describes the 
implementation of the purposefully built 
risk stratification tool in the Indiana 
Chronic Disease Management Program. 
Factors influencing implementation: Frequency of running tool; mechanism of 
distributing results; adapting own algorithm or user-interface; commissioning 
or partnering with vendor of the tool; centralised patient data; validating risk 
stratification tool results with patient surveys/clinical assessment; supportive 
policy environment. 
31 Smallcombe, 
Burge-Jones, 
PRISMATIC Study 
team et al. (2013) 
Wales, UK Prism Implementation guide − describes how 
to navigate online Prism interface, to 
register for use, and ensure correct 
interpretation of tool results for action. 
(n/a) 
Factors influencing implementation: Rules for granting access; end user friendly 
interface; training for end users; safeguarding against misuse or 
misinterpretation. 
32 Scottish 
Government 
Health Delivery 
Directorate (2010) 
Scotland, UK SPARRA Implementation guide − outlines what 
end users can expect when receiving 
notification of patient risk that have 
been established through use of tool as 
well as how to register; clean and utilise 
data. (n/a) 
Factors influencing implementation: One central data collection and processing 
unit; risk tool run for whole population centrally with information sent to 
primary carers regularly/or can be accessed through a secure online portal; GPs 
able to clean and adapt data once received; user-friendly interface (e.g. colour 
coding); connecting use of tool with a program of managed care 
33 Tuso, Huynh, 
Garofalo (2013) 
Kaiser 
Permanente 
Southern 
California 
LACE Evaluation – interrupted time series 
design. Patients were stratified into low- 
(LACE score 0-6), medium- (score 7-10) 
and high- (score 8 -11) risk categories. 
Different bundles of care were offered to 
patients accordingly. The program was 
implemented in all 13 KPSC medical 
centres discharging approximately 
40,000 Medicare risk patients each year 
during in the first quarter of 2012. (III-3) 
Among Medicare risk patients the observed over-expected admissions ratio 
reduced from approximately 1.0 – 0.8 between December 2010 to November 
2012.  During the same period readmission rates decreased from 12.8% to 
11%, respectively. 
Factors influencing implementation: Single EMR for all patients; linking hospital 
and primary care in risk stratification and care. 
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34 Zachariadou, 
Stoffers, Christophi 
et al. (2008) 
Cyprus SCORE Descriptive case study – the tool was 
applied to risk stratify 1011 patients with 
diagnosis type two diabetes mellitus 
hypertension or hyperlipidaemia living in 
Cyprus. The results of the stratification 
were used to assess the quality of care 
for patients with these conditions in the 
country and inform new care policy 
decisions. 
Implementation of SCORE was able to uncover under-treatment of patients 
with cardiovascular risk factors as well as under prescription of 
antihypertensive drugs, LLD and aspirin for high-risk groups. 
Factors influencing implementation: Quality of documentation of clinical 
information; training of end users. 
 
 
 
